var title_f4_45_4816="Pelger Huet anomaly";
var content_f4_45_4816=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F71990&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F71990&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Decreased nuclear lobes in myelodysplasia (pseudo Pelger-Huet anomaly)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 356px; height: 245px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Peripheral blood smear from a patient with refractory anemia with excess blasts (RAEB) shows a neutrophil with a bilobed pseudo-Pelger-Huet (Pelgeroid) nucleus. The two lobes are connected by a thin strand (arrow) giving a \"pince-nez\" appearance. These nuclei look identical to the those seen in the inherited Pelger-Huet anomaly. This neutrophil also has markedly reduced granulation, a finding commonly seen in the myelodysplastic syndromes.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     From Brunning, RD, McKenna, RW. Tumors of the bone marrow. Atlas of tumor pathology (electronic fascicle), Third series, fascicle 9, 1994, Washington, DC. Armed Forces Institute of Pathology.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_45_4816=[""].join("\n");
var outline_f4_45_4816=null;
var title_f4_45_4817="Parts of the stomach";
var content_f4_45_4817=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F79793&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F79793&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 576px\">",
"   <div class=\"ttl\">",
"    Parts of the stomach",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 556px; height: 415px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This drawing shows the parts of the anterior surface of the stomach. The body of the stomach is separated from the pyloric part by an oblique line which extends from the angular notch (incisura angularis) on the lesser curvature to the greater curvature.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_45_4817=[""].join("\n");
var outline_f4_45_4817=null;
var title_f4_45_4818="Germinal matrix hemorrhage";
var content_f4_45_4818=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F53684&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F53684&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Ultrasound of germinal matrix hemorrhage",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 348px; height: 292px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Ultrasonographic image (sagittal view) of a grade I germinal matrix hemorrhage (arrow) in a preterm newborn.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_45_4818=[""].join("\n");
var outline_f4_45_4818=null;
var title_f4_45_4819="Patient information: Pleuritic chest pain (The Basics)";
var content_f4_45_4819=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/17108\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?25/40/26244\">",
"         Pneumothorax (collapsed lung)",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?20/34/21027\">",
"         Patient information: Chest pain (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?33/27/34225\">",
"         Patient information: Costochondritis (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?1/35/1587\">",
"         Patient information: Medicines for angina (chest pain) (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?35/18/36130\">",
"         Patient information: Pneumonia in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?39/30/40418\">",
"         Patient information: Pneumothorax (collapsed lung) (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?23/32/24067\">",
"         Patient information: Pulmonary embolism (blood clot in the lungs) (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?42/9/43157\">",
"         Patient information: Chest pain (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?11/53/12115\">",
"         Patient information: Pericarditis (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?29/38/30308\">",
"         Patient information: Pneumonia in adults (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?2/29/2517\">",
"         Patient information: Pulmonary embolism (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?24/3/24624\">",
"         Patient information: Thoracentesis (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Pleuritic chest pain (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/pleuritic-chest-pain-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H26506099\">",
"      <span class=\"h1\">",
"       What is pleuritic chest pain?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Pleuritic chest pain is a type of pain that is caused by problems with the thin layers of tissue that surround the lungs (called the &ldquo;pleura&rdquo;). This type of pain feels like a sharp, stabbing chest pain, and it gets worse when you breathe in. &nbsp;",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H26506114\">",
"      <span class=\"h1\">",
"       What causes pleuritic chest pain?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Pleuritic chest pain can be caused by the following lung problems:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Pneumothorax &ndash; A pneumothorax is when air gets trapped between the lung and the rib cage (",
"        <a class=\"graphic graphic_figure graphicRef64892 \" href=\"UTD.htm?25/40/26244\">",
"         figure 1",
"        </a>",
"        ). This air presses on the lung and causes it to deflate or collapse. Causes of pneumothorax include injuries to the chest and certain lung infections.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Pleural effusion &ndash; Pleural effusion is when fluid builds up in the space between the lung and the rib cage. Causes of pleural effusion include tumors, pneumonia (an infection in the lungs), and blood clots in the lungs.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Pleuritis &ndash; Pleuritis is the medical term for inflammation of the pleura. This can also be called &ldquo;pleurisy.&rdquo; The most common cause of pleuritis is infection, but it can also be caused by lupus, rheumatoid arthritis, and certain medicines. &nbsp;",
"        <br/>",
"       </li>",
"       <li>",
"        Empyema &ndash; Empyema is the medical term for an infection in the fluid between the lung and the rib cage.",
"        <br/>",
"       </li>",
"       <li>",
"        Pericarditis &ndash; Pericarditis is a term for inflammation of the tissues around the heart. Sometimes the pain from pericarditis is similar to pleuritic chest pain.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H26506129\">",
"      <span class=\"h1\">",
"       Should I see a doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes, if you have stabbing chest pain that gets worse when you breathe in, see a doctor or nurse right away.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H26506144\">",
"      <span class=\"h1\">",
"       Are there tests I should have?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Your doctor or nurse will decide which tests you should have based on your age, other symptoms, and individual situation.",
"     </p>",
"     <p>",
"      Here are the most common tests doctors use to find the cause of pleuritic chest pain:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Blood tests &ndash; Blood tests can show whether you are fighting an infection, whether there is an infection in your blood, and whether your blood has certain proteins that get released into the blood during a heart attack.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Pulse oximetry &ndash; This test uses a small device that goes on your finger. It checks the amount of oxygen in your blood.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Chest X-ray &ndash; A chest X-ray can show if the lungs are inflating all the way. It can also show if there is air or fluid between the lungs and the ribcage",
"        <br/>",
"       </li>",
"       <li>",
"        CT scan &ndash; A chest CT scan can show if there is a blood clot in the lung, and find other causes of pleuritic pain.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Thoracentesis &ndash; During this procedure, doctors use a needle to take some fluid from around the lungs. Then they can test the fluid for infection and find out what kind of cells it has in it. (This test is only for people who have fluid around the lungs.)",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Heart tests &ndash; Because heart problems can cause chest pain, some people with pleuritic chest pain have heart tests. These tests could include an electrocardiogram (ECG), which measures the electrical activity of the heart, or an echocardiogram, which uses sound waves to create pictures of the heart as it beats.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H26506159\">",
"      <span class=\"h1\">",
"       How is pleuritic chest pain treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;That depends on what kind of problem is causing the pain.",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Pneumothorax &ndash; Sometimes a pneumothorax will heal on its own. If a pneumothorax is too big to heal on its own, doctors can drain the air in the pneumothorax using a tube (called a chest tube).",
"       </li>",
"       <li>",
"        Pneumonia with empyema caused by bacteria &ndash; If the pain is caused by a bacterial infection in the fluid around the lung, doctors can treat the infection with antibiotics. Often they also use a chest tube to help drain the infection.",
"       </li>",
"       <li>",
"        Blood clot &ndash; If the pain is caused by a blood clot, doctors give medicine that dissolves clots or keeps them from getting bigger.",
"       </li>",
"       <li>",
"        Medicines &ndash; If a medicine is causing pleuritis, doctors might stop or switch the medicine.",
"       </li>",
"       <li>",
"        Viral infection &ndash; If the pain is not caused by any of the problems listed above, it is probably caused by a viral infection. Viral infections usually go away on their own after a few days or a couple of weeks. To help with pain in the meantime, doctors often suggest pain-relieving medicines, such as&nbsp;",
"        <a class=\"drug drug_patient\" href=\"UTD.htm?14/17/14614?source=see_link\">",
"         ibuprofen",
"        </a>",
"        (sample brand names: Advil&reg;, Motrin&reg;) or",
"        <a class=\"drug drug_patient\" href=\"UTD.htm?43/35/44597?source=see_link\">",
"         naproxen",
"        </a>",
"        &nbsp;(sample brand names: Aleve&reg;, Naprosyn&reg;).",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H26506174\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?23/32/24067?source=see_link\">",
"       Patient information: Pulmonary embolism (blood clot in the lungs) (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?20/34/21027?source=see_link\">",
"       Patient information: Chest pain (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?35/18/36130?source=see_link\">",
"       Patient information: Pneumonia in adults (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?39/30/40418?source=see_link\">",
"       Patient information: Pneumothorax (collapsed lung) (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?33/27/34225?source=see_link\">",
"       Patient information: Costochondritis (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?1/35/1587?source=see_link\">",
"       Patient information: Medicines for angina (chest pain) (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?42/9/43157?source=see_link\">",
"       Patient information: Chest pain (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?11/53/12115?source=see_link\">",
"       Patient information: Pericarditis (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?29/38/30308?source=see_link\">",
"       Patient information: Pneumonia in adults (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?2/29/2517?source=see_link\">",
"       Patient information: Pulmonary embolism (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?24/3/24624?source=see_link\">",
"       Patient information: Thoracentesis (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?4/45/4819?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 17108 Version 2.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-200.131.240.2-FE77A46CF4-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_45_4819=[""].join("\n");
var outline_f4_45_4819=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26506099\">",
"      What is pleuritic chest pain?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26506114\">",
"      What causes pleuritic chest pain?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26506129\">",
"      Should I see a doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26506144\">",
"      Are there tests I should have?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26506159\">",
"      How is pleuritic chest pain treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26506174\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/17108\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?25/40/26244\">",
"      Pneumothorax (collapsed lung)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?42/9/43157?source=related_link\">",
"      Patient information: Chest pain (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?20/34/21027?source=related_link\">",
"      Patient information: Chest pain (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?33/27/34225?source=related_link\">",
"      Patient information: Costochondritis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?1/35/1587?source=related_link\">",
"      Patient information: Medicines for angina (chest pain) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?11/53/12115?source=related_link\">",
"      Patient information: Pericarditis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?29/38/30308?source=related_link\">",
"      Patient information: Pneumonia in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?35/18/36130?source=related_link\">",
"      Patient information: Pneumonia in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?39/30/40418?source=related_link\">",
"      Patient information: Pneumothorax (collapsed lung) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?2/29/2517?source=related_link\">",
"      Patient information: Pulmonary embolism (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?23/32/24067?source=related_link\">",
"      Patient information: Pulmonary embolism (blood clot in the lungs) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?24/3/24624?source=related_link\">",
"      Patient information: Thoracentesis (Beyond the Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f4_45_4820="Procainamide: Patient drug information";
var content_f4_45_4820=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Procainamide: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/34/36391?source=see_link\">",
"     see \"Procainamide: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/18/38182?source=see_link\">",
"     see \"Procainamide: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F213545\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Procainamide&reg;;",
"     </li>",
"     <li>",
"      Procainamide Hydrochloride Injection, USP;",
"     </li>",
"     <li>",
"      Procan SR&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10028005\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700416",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Long-term use of procainamide may cause lupus, a disease that causes irritation to joints and other parts of the body. Talk with the doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10028007\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691662",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat a fast heartbeat.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10028006\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702797",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to procainamide or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701383",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a slow heartbeat without a working pacemaker or lupus.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10028010\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697148",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a weak heart, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697296",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have low potassium levels or if you are taking a water pill, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697312",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have myasthenia gravis, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10028011\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698207",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Low blood pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698304",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Procainamide may cause a lupus-like disease. This will most often go away.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10028013\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698655",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698981",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to eat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698967",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Joint pain or swelling.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10028009\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695991",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695989",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein over a period of time.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10028014\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699596",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10028015\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11411 Version 32.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-103.10.120.51-1F944A4537-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_45_4820=[""].join("\n");
var outline_f4_45_4820=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F213545\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028005\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028007\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028006\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028010\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028011\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028013\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028009\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028014\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028015\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?35/34/36391?source=related_link\">",
"      Procainamide: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/18/38182?source=related_link\">",
"      Procainamide: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f4_45_4821="Assessment of disease status and surveillance after treatment in patients with brain tumors";
var content_f4_45_4821=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Assessment of disease status and surveillance after treatment in patients with brain tumors",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/45/4821/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/45/4821/contributors\">",
"     Patrick Y Wen, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/45/4821/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/45/4821/contributors\">",
"     Jay S Loeffler, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/45/4821/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/45/4821/contributors\">",
"     April F Eichler, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?4/45/4821/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 19, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients with primary brain tumors, appropriate management requires a determination of whether a patient is responding to therapy or is progressing. The integration of improvements in neuroimaging (MRI, CT, newer techniques) provides valuable information, but significant issues remain.",
"   </p>",
"   <p>",
"    Developments in response criteria, for both malignant gliomas and low-grade gliomas, are reviewed here. The management of these tumors is discussed separately:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/60/35784?source=see_link\">",
"       \"Clinical manifestations and initial surgical approach to patients with malignant gliomas\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/25/42391?source=see_link\">",
"       \"Adjuvant chemotherapy for malignant gliomas\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/38/4712?source=see_link\">",
"       \"Adjuvant radiation therapy for malignant gliomas\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/33/44568?source=see_link\">",
"       \"Management of low-grade glioma\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1576579521\">",
"    <span class=\"h1\">",
"     MALIGNANT GLIOMAS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Malignant (grade III or IV) gliomas are best managed with a combined modality approach, incorporating adjuvant postoperative radiation therapy (RT) and adjuvant chemotherapy following initial surgery. Despite aggressive therapy, most patients eventually develop progressive or recurrent disease, and require multiple courses of treatment to provide optimal care.",
"   </p>",
"   <p>",
"    For patients on clinical trials, the gold standard is prolongation of overall survival in randomized trials, and this approach has been used with both radiation therapy and chemotherapy.",
"   </p>",
"   <p>",
"    Assessment of overall survival in randomized trials is subject to limitations. Crossover from one treatment to another or the use of subsequent therapy can obscure the benefit derived from one treatment in the original randomization. In addition, overall survival cannot be used as a decision-making tool for individual patients.",
"   </p>",
"   <p>",
"    An alternative to address some of these issues has been the use of progression-free survival (PFS), either as a median duration or by use of a landmark such as PFS at six months. The use of PFS, both in clinical trials and for individual patients, requires an accurate and consistent definition of progression. Without such a definition, there is a risk that efficacious therapy will be discontinued prematurely or that an ineffective treatment will be continued without benefit. Effective criteria are also important in the conduct of clinical trials for the development of new agents in patients with malignant brain tumors.",
"   </p>",
"   <p>",
"    The Macdonald criteria for the assessment of response and progression were originally promulgated in 1990 and have been the standard approach for patients with malignant glial tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4821/abstract/1\">",
"     1",
"    </a>",
"    ]. However, these criteria are subject to a number of significant limitations. Thus new criteria have been proposed by the Response Assessment in Neuro-Oncology (RANO) Working Group to address these issues [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4821/abstract/2\">",
"     2",
"    </a>",
"    ]. Both of these approaches are discussed here.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h2\">",
"     Macdonald criteria",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h3\">",
"     Definitions",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Macdonald criteria rely upon changes in two-dimensional tumor area, as defined by contrast enhancement on CT or MRI [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4821/abstract/1\">",
"     1",
"    </a>",
"    ]. These criteria defined four outcomes:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Complete response: Complete disappearance of all tumor on consecutive CT or MRI scans at least one month apart, off steroids.",
"     </li>",
"     <li>",
"      Partial response: Greater than or equal to a 50 percent decrease in area of enhancing tumor on consecutive imaging studies at least one month apart. Doses of steroids must be stable or decreased and the patient must be neurologically stable.",
"     </li>",
"     <li>",
"      Progressive disease: Greater than or equal to a 25 percent increase in size of enhancing tumor or any new tumor on CT or MRI.",
"     </li>",
"     <li>",
"      Stable disease: All other situations.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Limitations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Increasing experience and improvements in tumor imaging with MRI and the availability of new antiangiogenic agents have helped to highlight a number of important limitations associated with the Macdonald criteria [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4821/abstract/2\">",
"     2",
"    </a>",
"    ]. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pseudoprogression: The standard approach to treatment of malignant gliomas includes surgery, followed by radiation therapy and concurrent and adjuvant chemotherapy. Approximately one-fourth of patients have evidence of pseudoprogression, which is manifested by increased contrast enhancement at the first reimaging and which then resolves despite continued therapy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/25/42391?source=see_link\">",
"       \"Adjuvant chemotherapy for malignant gliomas\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/38/4712?source=see_link\">",
"       \"Adjuvant radiation therapy for malignant gliomas\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/30/36328?source=see_link&amp;anchor=H2#H2\">",
"       \"Management of recurrent malignant gliomas\", section on 'Early progression versus pseudoprogression'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Surgical changes: Surgical changes can result in increased enhancement in the wall of the surgical cavity in the first 48 to 72 hours after surgery [",
"      <a class=\"abstract\" href=\"UTD.htm?4/45/4821/abstract/3\">",
"       3",
"      </a>",
"      ]. Such areas of contrast enhancement must be distinguished from residual tumor that was not resected. A baseline MRI obtained within 24 to 48 hours after surgery can avoid confusing such enhancement with residual contrast-enhancing tumor.",
"     </li>",
"     <li>",
"      Antiangiogenic therapy: Antiangiogenic agents such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/20/2377?source=see_link\">",
"       bevacizumab",
"      </a>",
"      can normalize tumor vasculature, which can result in decreased contrast enhancement within one to two days of initial treatment. The disparity between observed a very high response rate with these agents based upon resolution of contrast enhancement and a limited effect on overall survival suggest that these changes may not correlate with actual tumor regression. This improvement in contrast enhancement due to diminished vascular permeability does not necessarily reflect a true antitumor effect and has been referred to as a &ldquo;pseudoresponse&rdquo; [",
"      <a class=\"abstract\" href=\"UTD.htm?4/45/4821/abstract/4\">",
"       4",
"      </a>",
"      ]. In addition, a subset of patients who progress on antiangiogenic therapy have nonenhancing tumor that is not taken into account by the Macdonald Criteria. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/30/36328?source=see_link&amp;anchor=H12#H12\">",
"       \"Management of recurrent malignant gliomas\", section on 'Bevacizumab'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Other issues that are not adequately addressed by the Macdonald criteria include irregularly shaped tumors, multiple tumors, and enhancing lesions in cyst walls following surgery.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     RANO criteria",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Response Assessment in Neuro-Oncology (RANO) Working Group is an international, multidisciplinary group that is developing criteria that can address the limitations that are present in the Macdonald criteria [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4821/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Key features of the proposed RANO criteria that differ from the Macdonald criteria include [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4821/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      During the first twelve weeks after completion of chemoradiotherapy, progressive disease requires contrast enhancement outside the radiation therapy field or histologic evidence of viable tumor on a biopsy sample in order to avoid confusing progressive disease with pseudoprogression. Clinical deterioration alone is not adequate to define progression during this initial period.",
"     </li>",
"     <li>",
"      After the first 12 weeks, criteria for progressive disease include new contrast enhancement outside the radiation field or an increase in size of the original lesion. For patients receiving an antiangiogenic agent such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/20/2377?source=see_link\">",
"       bevacizumab",
"      </a>",
"      , the diagnosis of progressive disease can also be based upon an increase in size of a nonenhancing lesion, as visualized using T2 weighted or fluid attenuation inversion recover (FLAIR) magnetic resonance image (MRI) sequences.",
"     </li>",
"     <li>",
"      The definitions for complete response, partial response, and stable disease are similar to those for the Macdonald criteria. However, these now incorporate the results obtained from T2 or FLAIR images for nonenhancing lesions.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The RANO criteria have been formulated for incorporation into clinical trials, and further validation of these guidelines is required [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4821/abstract/2\">",
"     2",
"    </a>",
"    ]. However, the issues raised by these criteria, particularly concerns about pseudoprogression and the evidence for progressive disease in situations not meeting the Macdonald criteria, are also applicable.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1576579620\">",
"    <span class=\"h1\">",
"     LOW-GRADE GLIOMAS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Assessment of response and progression in patients with low-grade gliomas is more difficult than for malignant gliomas [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4821/abstract/5\">",
"     5",
"    </a>",
"    ]. Key issues include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Slow growth rate of these tumors until they undergo malignant transformation",
"     </li>",
"     <li>",
"      Lack of contrast enhancement in the majority of cases",
"     </li>",
"     <li>",
"      Poor correlation between tumor imaging findings and clinical parameters of cognition and health related quality of life",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Overall survival is limited as a tool in assessing treatment efficacy clinical trials because of the prolonged median survival (five years or more) and because of the confounding effects due to salvage therapies.",
"   </p>",
"   <p>",
"    Progression-free survival has often been used in assessing the efficacy of investigational agents. However, assessment of progression can be subjective and is particularly difficult because of the difficulties in accurately imaging low-grade gliomas. Progression-free survival has not been validated as an end point, and its correlation with overall survival is uncertain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1576579640\">",
"    <span class=\"h2\">",
"     Imaging criteria",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the vast majority of cases, low-grade gliomas do not exhibit contrast enhancement [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4821/abstract/5\">",
"     5",
"    </a>",
"    ]. Thus, the Macdonald criteria that are used in patients with malignant gliomas usually cannot be applied. The diagnosis and subsequent assessment of low-grade gliomas is based upon T2 or FLAIR magnetic resonance image sequences for nonenhancing lesions, which are relatively poor in assessing small changes. Newer approaches, such as functional imaging (PET), may eventually be more effective as predictors of tumor control and patient survival than tumor size measurement by MRI or CT, but currently these remain experimental.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1576580157\">",
"    <span class=\"h2\">",
"     Clinical issues",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is a relatively poor correlation between imaging findings and clinical relevant endpoints. These include cognitive function, symptom burden, seizure activity, and the need for corticosteroids, all of which contribute significantly to the overall health-related quality of life. Each of these parameters needs to be considered prospectively assessed both in the clinical trial setting and in the management of an individual patient.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1576579664\">",
"    <span class=\"h2\">",
"     RANO criteria",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Response Assessment in Neuro-Oncology (RANO) Working Group has proposed specific criteria for patients with low-grade gliomas [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4821/abstract/5\">",
"     5",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Complete response &ndash; Complete disappearance of the original lesion on T2 or FLAIR magnetic resonance image sequences and the absence of any new lesions or imaging abnormalities other than those attributable to treatment. Patients should be clinically improved or stable and off steroids or on physiologic replacement doses only. Complete response status should be sustained for at least four weeks.",
"     </li>",
"     <li>",
"      Partial response &ndash; A greater than 50 percent decrease in the product of the perpendicular diameters on T2 or FLAIR magnetic resonance image sequences without new lesions, sustained for at least four weeks. Clinically, a patient should be stable or improved and there should be no increase in baseline steroid requirements.",
"     </li>",
"     <li>",
"      Minor response &ndash; A response of greater than 25 but less than 50 percent in the product of the perpendicular diameters on",
"      <span class=\"nowrap\">",
"       T2/FLAIR",
"      </span>",
"      magnetic resonance image sequences without new lesions. Clinically, a patient should be stable or improved and there should be no increase in baseline steroid requirements.",
"     </li>",
"     <li>",
"      Stable disease &ndash; No change in imaging that meets the requirements for response (complete, partial, or minor) or progression. Clinically, a patient should be stable and there should be no increase in baseline steroid requirements.",
"     </li>",
"     <li>",
"      Progression &ndash; Progression based upon imaging requires the development of new lesions, radiologic evidence of transformation to a malignant glioma (increase in contrast enhancement) or a 25 percent increase in size on T2 or FLAIR magnetic resonance image sequences of a nonenhancing lesion on stable or increasing doses of corticosteroids that is not attributable to treatment effect. Alternatively, progression is defined based upon clinical criteria that include definite clinical deterioration that is not due to other causes or to decreasing doses of corticosteroids.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H701992677\">",
"    <span class=\"h1\">",
"     SURVEILLANCE AFTER TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no formal clinical trials that define the optimal frequency for follow-up after treatment. The following guidelines are consistent with those from the National Comprehensive Cancer Network (NCCN) for follow-up imaging [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4821/abstract/6\">",
"     6",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For patients with malignant gliomas, a repeat MRI should be obtained four weeks after completion of radiation therapy, then every two to four months for two to three years, and less frequently thereafter.",
"     </li>",
"     <li>",
"      For patients with low-grade gliomas, a repeat MRI should be obtained every three to six months for five years, and then at least annually thereafter.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For patients with a malignant glioma, the assessment of disease status depends upon multiple factors, including the characteristics of the tumor on imaging (MRI, CT), overall clinical status, and use of steroids. (See",
"      <a class=\"local\" href=\"#H1576579521\">",
"       'Malignant gliomas'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The Macdonald criteria use the size of tumor, which relies upon contrast enhancement and is dependent upon abnormalities in tumor vasculature. Limitations of the Macdonald criteria include overestimation of progressive disease in patients with pseudoprogression, a failure to recognize the importance of non-contrast enhancing disease as detected by",
"      <span class=\"nowrap\">",
"       T2/FLAIR",
"      </span>",
"      sequences, and the impact of antiangiogenic therapy in reducing the vascular abnormalities associated with malignant gliomas. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Macdonald criteria'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The Response Assessment in Neuro-Oncology (RANO) Working Group has developed new criteria that attempt to address the limitations of the Macdonald criteria. Although the RANO criteria have been developed with a primary focus on clinical trials, the issues raised in these criteria need to be considered in the care of patients with malignant gliomas outside of clinical trials as well. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'RANO criteria'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For patients with low-grade gliomas, assessment of response and progression is difficult because of the slow growth rate of these tumors, their prolonged natural history, and the limited ability of imaging studies, including T2 and FLAIR magnetic resonance image sequences, to accurately define response and progression. Newly developed proposed criteria from the Response Assessment in Neuro-Oncology (RANO) Working Group integrate both imaging and clinical criteria in assessing response. (See",
"      <a class=\"local\" href=\"#H1576579620\">",
"       'Low-grade gliomas'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4821/abstract/1\">",
"      Macdonald DR, Cascino TL, Schold SC Jr, Cairncross JG. Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 1990; 8:1277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4821/abstract/2\">",
"      Wen PY, Macdonald DR, Reardon DA, et al. Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol 2010; 28:1963.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4821/abstract/3\">",
"      Cairncross JG, Pexman JH, Rathbone MP, DelMaestro RF. Postoperative contrast enhancement in patients with brain tumor. Ann Neurol 1985; 17:570.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4821/abstract/4\">",
"      Reardon DA, Galanis E, DeGroot JF, et al. Clinical trial end points for high-grade glioma: the evolving landscape. Neuro Oncol 2011; 13:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4821/abstract/5\">",
"      van den Bent MJ, Wefel JS, Schiff D, et al. Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas. Lancet Oncol 2011; 12:583.",
"     </a>",
"    </li>",
"    <li>",
"     NCCN guidelines file://www.nccn.org/professionals/physician_gls/f_guidelines.asp#site.",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5208 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-115.25.216.6-A93D27A9D4-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_45_4821=[""].join("\n");
var outline_f4_45_4821=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H6\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1576579521\">",
"      MALIGNANT GLIOMAS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      Macdonald criteria",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      - Definitions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Limitations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      RANO criteria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1576579620\">",
"      LOW-GRADE GLIOMAS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1576579640\">",
"      Imaging criteria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1576580157\">",
"      Clinical issues",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1576579664\">",
"      RANO criteria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H701992677\">",
"      SURVEILLANCE AFTER TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/25/42391?source=related_link\">",
"      Adjuvant chemotherapy for malignant gliomas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/38/4712?source=related_link\">",
"      Adjuvant radiation therapy for malignant gliomas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/60/35784?source=related_link\">",
"      Clinical manifestations and initial surgical approach to patients with malignant gliomas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/33/44568?source=related_link\">",
"      Management of low-grade glioma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/30/36328?source=related_link\">",
"      Management of recurrent malignant gliomas",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f4_45_4822="ERCP in children: Technique, success and complications";
var content_f4_45_4822=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   ERCP in children: Technique, success and complications",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/45/4822/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/45/4822/contributors\">",
"     Moises Guelrud, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/45/4822/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/45/4822/contributors\">",
"     George D Ferry, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/45/4822/contributors\">",
"     Douglas A Howell, MD, FASGE, FACG",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/45/4822/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/45/4822/contributors\">",
"     Alison G Hoppin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?4/45/4822/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 12, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Experience with endoscopic retrograde cholangiopancreatography (ERCP) in children has been limited due to multiple factors, including the relatively low incidence of diseases requiring ERCP in this age group, the impression that the procedure is technically difficult in children, and because the indications and safety of ERCP in children have not been well defined. As a result, patients are generally referred to a tertiary care facility or to adult endoscopists who perform a high volume of procedures.",
"   </p>",
"   <p>",
"    This topic review will focus on the technical aspects of performing ERCP in children. Indications for ERCP in children are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/3/20536?source=see_link\">",
"     \"ERCP for biliary disease in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/33/24088?source=see_link\">",
"     \"ERCP for pancreatic disease in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATIENT PREPARATION AND SEDATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because most ERCP procedures in children are performed by adult gastroenterologists, a close working collaboration between an adult and a pediatric gastroenterologist is important during patient preparation and the procedure itself. The preparation and sedation of a child undergoing ERCP is similar to that used for upper gastrointestinal endoscopy. The procedure should be explained to the child in a manner appropriate for the age and level of intellectual and emotional development.",
"   </p>",
"   <p>",
"    The endoscopist must choose between conscious sedation and general anesthesia after considering the pertinent risks and taking into account personal skill and experience and the expected complexity of the procedure. A state of deep sedation from which the patient is not easily aroused is often required, since young children and some adolescents cannot fully cooperate with procedures under lesser degrees of conscious sedation. Most children can be sedated adequately with a combination of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/44/11976?source=see_link\">",
"     meperidine",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/52/38730?source=see_link\">",
"     fentanyl",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/46/16105?source=see_link\">",
"     diazepam",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/60/4042?source=see_link\">",
"     midazolam",
"    </a>",
"    . Children frequently require much higher doses of midazolam on a milligram per kilogram basis than adults. In occasions, children can also be sedated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/25/17816?source=see_link\">",
"     propofol",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    Postprocedure monitoring is the same as for other endoscopic procedures requiring sedation. Personnel with appropriate training in pediatric sedation and monitoring are required for either conscious sedation or general anesthesia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ANTIBIOTIC PROPHYLAXIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no data to guide recommendations for antibiotic prophylaxis for ERCP in children. As a result, the principles of antibiotic prophylaxis in adults are frequently applied in children. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/25/41367?source=see_link\">",
"     \"Antibiotic prophylaxis for gastrointestinal endoscopic procedures\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    ERCP is generally associated with a higher risk for bacteremia than upper endoscopy alone, particularly in the presence of biliary obstruction. We suggest the following approach:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with cystic or obstructing lesions of the biliary or pancreatic ducts should be given antibiotic prophylaxis to prevent cholangitis or infective pancreatitis.",
"     </li>",
"     <li>",
"      Antibiotic prophylaxis should be considered on an individual patient basis in organ transplant recipients, those who are otherwise immunocompromised, and patients with indwelling catheters.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     ENDOSCOPIC EQUIPMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;ERCP is performed in neonates and infants younger than 12 months with a pediatric duodenoscope which has an insertion tube diameter of 7.5 mm, a channel of 2.0 mm, and an elevator [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4822/abstract/1\">",
"     1",
"    </a>",
"    ]. Use of a pediatric duodenoscope is mandatory in neonates and in infants younger than 12 months and is preferred for children younger than three years. A standard adult duodenoscope (insertion tube diameter approximately 11 mm) can be used in older children and adolescents.",
"   </p>",
"   <p>",
"    Pediatric duodenoscopes with a 2.0 mm channel permit passage of catheters up to 5 FR diameter. More complicated therapeutic maneuvers, such as placement of endoprostheses and passage of some dilators and retrieval baskets, require instruments with a larger (3.2 mm) channel. An adult duodenoscope with all the accessories should be available for therapeutic interventions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     TECHNIQUE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Medications that may be useful during ERCP include glucagon and buscopan (hyoscine-N-butyl bromide) to reduce duodenal motility, and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/49/28435?source=see_link\">",
"     secretin",
"    </a>",
"    to facilitate identification and cannulation of the minor papilla.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22754217\">",
"    <span class=\"h2\">",
"     Endoscope insertion and position",
"    </span>",
"    &nbsp;&mdash;&nbsp;The duodenoscope is inserted into the second portion of the duodenum with the patient in the prone position. The optimal route to the papilla is the \"short route,\" which involves straightening the instrument along the lesser curvature of the stomach to bring the papilla directly en face. The instrument is withdrawn slowly, keeping the controls locked and the papilla in view. This involves rotating the scope to the right while angling the tip up. In some infants it is not possible to perform this maneuver. In such cases cannulation of the papilla is performed with the \"long route,\" in which the instrument lies along the greater curvature of the stomach. Control of the endoscope tip and elevator are more difficult in this configuration, and there is more discomfort.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22754210\">",
"    <span class=\"h2\">",
"     Cannulation of the papilla",
"    </span>",
"    &nbsp;&mdash;&nbsp;The principles of cannulation are similar to those used in adult patients, with the additional limitations of space within the duodenum in small patients. A tapered Teflon catheter (3.5 F at the distal end) or a mini-sphincterotome (4 F at the distal end) is introduced into the papilla. A 65 percent iodinated contrast agent is injected manually using a 5 or 10 mL syringe. While some endoscopists prefer nonionic low osmolar agents, there is no proof that these more expensive agents reduce the incidence of post-ERCP pancreatitis [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4822/abstract/2\">",
"     2",
"    </a>",
"    ]. Dilution of the contrast material to 30 percent is preferred for optimal visualization if ducts are known to be dilated or if filling defects are anticipated. Meticulous fluoroscopy is equally if not more important than the concentration of contrast for optimal imaging; filling of common bile duct or pancreatic duct should be monitored continuously during contrast injection.",
"   </p>",
"   <p>",
"    It is important to minimize the procedure time to avoid abdominal over-distension and respiratory compromise, especially in young infants, such as those undergoing investigation for neonatal cholestasis. In our experience the mean time from introduction of the duodenoscope into the mouth to complete withdrawal is 10 minutes, with a range of 2 to 20 minutes. To reduce the time of the procedure, the cannula is placed into the biopsy channel of the duodenoscope prior to passage, and the instrument is withdrawn as soon as the common bile duct is identified fluoroscopically. If contrast does not enter the common bile duct but only refluxes to the duodenum, or if only the pancreatic duct is visualized, the cannula is left in the curved cephalad position and the endoscope is slowly withdrawn. This may change the cannula tip orientation and straighten out the route from the papillary orifice to the common duct. Lateral and vertical angulation of the cannula should be tried if these attempts are unsuccessful. It is helpful to engage the orifice with the cannula tip and then rotate the scope tip and cannula to the left, followed by orientation of the cannula tip in the cephalad direction. Deep selective cannulation of the bile duct is generally not possible for neonates given the small duct diameter.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22754239\">",
"    <span class=\"h2\">",
"     Monitoring",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because ERCP requires fluoroscopy, it is usually performed in a radiology suite designed for adult patients. Pediatric endoscopy assistants and specially trained nurses can help reduce preprocedure anxiety, monitor the clinical status of the patient, assist in holding and reassuring, and administering medications, handling catheters, and injecting contrast material. The heart rate and oxygen saturation must be continuously monitored. Resuscitation medications and appropriate equipment should be available. A recovery area equipped with monitors and specialized pediatric nurses familiar with the needs of children is necessary.",
"   </p>",
"   <p>",
"    ERCP can be performed on an ambulatory basis when performed for diagnosis only. Therapeutic ERCP has a greater potential risk for serious complications and overnight observation in the hospital may be indicated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     SUCCESS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In children older than one year and adolescents, the rate of successful cannulation is more than 95 percent, comparable to reports in adults [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4822/abstract/3-22\">",
"     3-22",
"    </a>",
"    ]. In neonates and young infants, the rate of successful cannulation of the common bile duct is often lower than in adults, ranging from 27 to 95 percent in various reports [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4822/abstract/1,3,23-32\">",
"     1,3,23-32",
"    </a>",
"    ]. Experience of the endoscopists may account for a large part of the variability. &nbsp;",
"   </p>",
"   <p>",
"    In our unpublished experience, the procedure was successful in 98 percent of children older than one year (216 of 220 cases). Our ERCP success in neonates and young infants with neonatal cholestasis was 93 percent (171 of 184 cases). The procedure was unsuccessful in thirteen patients because of duodenal malrotation in two and inability to cannulate in eleven.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of complications in children has not been well established. In children older than one year, complication rates are between 3 and 10 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4822/abstract/7,10,23,25,27,29,31-33\">",
"     7,10,23,25,27,29,31-33",
"    </a>",
"    ]. Complications include pancreatitis, infection, hemorrhage, and perforation, and are more common among patients undergoing therapeutic ERCP as compared with diagnostic ERCP. Major complications are rare.",
"   </p>",
"   <p>",
"    The range and frequency of complications are illustrated by the following case series:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One of the largest series included 245 children (mean age 12 years) who underwent 329 diagnostic or therapeutic examinations for a variety of biliary or pancreatic disorders [",
"      <a class=\"abstract\" href=\"UTD.htm?4/45/4822/abstract/32\">",
"       32",
"      </a>",
"      ]. There were a total of 32 complications (10 percent), most of which were pancreatitis. There were no deaths.",
"     </li>",
"     <li>",
"      In another series, 61 children (mean age 7 years, range 3 days to 16.9 years) underwent a total of 99 ERCPs [",
"      <a class=\"abstract\" href=\"UTD.htm?4/45/4822/abstract/33\">",
"       33",
"      </a>",
"      ]. Of these patients, 51 percent were younger than one year, 84 percent had biliary indications, and 16 percent had pancreatic indications for the procedure. The complication rate was 4 percent",
"      <span class=\"nowrap\">",
"       (4/99),",
"      </span>",
"      and included marked pancreatitis and transient mild elevations of pancreatic enzymes.",
"     </li>",
"     <li>",
"      In our unpublished experience with 125 ERCPs in children older than one year, we had two complications (1.6 percent). Of 75 patients with biliary disorders, one patient with choledochal cyst and cystolithiasis had acute cholangitis that improved with antibiotics. Of 50 children with pancreatic disorders, there was one case of mild acute ERCP-related pancreatitis in a patient with recurrent pancreatitis and sphincter of Oddi dysfunction.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It is unclear whether complication rates are slightly higher in infants younger than one year [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4822/abstract/1,23-30\">",
"     1,23-30",
"    </a>",
"    ]. One of the large series cited above reported no complications in children younger than one year [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4822/abstract/33\">",
"     33",
"    </a>",
"    ]. In our unpublished experience with 184 neonates and young infants, minor complications without clinical significance occurred in 24 patients (13 percent), which is higher than our complication rate in children older than one year (1.6 percent). Two neonates had transient opiate-induced respiratory depression, and four young infants had non-opioid respiratory depression, which resolved with oxygen administration. In 17 patients, minor acute duodenal erosions were observed without clinical consequences. One neonate had abdominal distention for 10 hours after completion of ERCP, which resolved without treatment. There were no major complications in either series.",
"   </p>",
"   <p>",
"    Pancreatitis may be a more common complication of ERCP among children with underlying pancreatitis as compared with those undergoing ERCP for other indications. In a series of 42 ERCP examinations in 37 children and one young adult, all of whom had a history of pancreatitis, mild pancreatitis was observed in three patients (8 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4822/abstract/7\">",
"     7",
"    </a>",
"    ]. No patients with biliary tract pathology developed pancreatitis. Another series reported ten cases of post-ERCP pancreatitis in 67 patients undergoing ERCP for chronic pancreatitis (15 percent). The rate of post-ERCP pancreatitis was highest in the patients undergoing pancreatic duct stent placement (7 of 28 procedures; 25 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4822/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    To minimize the risk of pancreatitis, a sphincterotome with a guidewire can be used for cannulation. Under fluoroscopic control, the guidewire is advanced into the common bile duct, then the sphincterotome is advanced and contrast injected. This approach avoids injection of contrast into the pancreatic duct and reduces the risk of pancreatitis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22754173\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Endoscopic retrograde cholangiopancreatography (ERCP) in infants and children is generally performed at a tertiary care facility, or by adult endoscopists who perform a high volume of procedures. In either case, the team must include providers with pediatric experience for patient preparation and for the procedure itself. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Patient preparation and sedation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      ERCP in infants and children can be performed under conscious sedation or general anesthesia. The choice depends on the pertinent risks, skill and experience of the endoscopist, and the expected complexity of the procedure. Personnel with appropriate training in pediatric sedation and monitoring are required for either conscious sedation or general anesthesia. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Patient preparation and sedation'",
"      </a>",
"      above.) &nbsp;",
"     </li>",
"     <li>",
"      ERCP is generally associated with a higher risk for bacteremia than upper endoscopy alone, particularly in the presence of biliary obstruction. In general, patients with cystic or obstructing lesions of the biliary or pancreatic ducts should be given antibiotic prophylaxis to prevent cholangitis or infective pancreatitis. Prophylaxis is sometimes appropriate for organ transplant recipients, those who are otherwise immunocompromised, and patients with indwelling catheters. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Antibiotic prophylaxis'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/25/41367?source=see_link\">",
"       \"Antibiotic prophylaxis for gastrointestinal endoscopic procedures\"",
"      </a>",
"      .) &nbsp;",
"     </li>",
"     <li>",
"      Use of a pediatric duodenoscope (insertion tube diameter of 7.5 mm, a channel of 2.0 mm, and an elevator) is mandatory in neonates and in infants younger than 12 months and is preferred for children younger than three years. A standard adult duodenoscope (insertion tube diameter approximately 11 mm) can be used in older children and adolescents. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Endoscopic equipment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The principles of cannulation are similar to those used in adult patients, but special techniques may be required in small patients because of the limited space within the duodenum and small size of the common bile duct. It is important to minimize the procedure time to avoid abdominal over-distension and respiratory compromise, especially in young infants. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Technique'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In children older than one year and adolescents, the rate of successful cannulation of the common bile duct at ERCP is comparable to reports in adults. In neonates and young infants, the rate of successful cannulation of the common bile duct is often lower than in adults, ranging from 27 to 95 percent in various reports. Experience of the endoscopists may account for a large part of the variability. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Success'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Complications of ERCP include pancreatitis, infection, hemorrhage, and perforation, and are more common among patients undergoing therapeutic ERCP as compared with diagnostic ERCP. In children older than one year, complication rates of ERCP are between 3 and 10 percent. Major complications are rare. Pancreatitis may be a more common complication of ERCP among children with underlying pancreatitis as compared with those undergoing ERCP for other indications. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Complications'",
"      </a>",
"      above.) &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4822/abstract/1\">",
"      Guelrud M, Jaen D, Torres P, et al. Endoscopic cholangiopancreatography in the infant: evaluation of a new prototype pediatric duodenoscope. Gastrointest Endosc 1987; 33:4.",
"     </a>",
"    </li>",
"    <li>",
"     Standards of Practice Committee of the American Society for Gastrointestinal Endoscopy. Radiographic contrast media used in ERCP. May 1995.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4822/abstract/3\">",
"      Dua K, Miranda A, Santharam R, et al. ERCP in the evaluation of abdominal pain in children. Gastrointest Endosc 2008; 68:1081.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4822/abstract/4\">",
"      Cotton PB, Laage NJ. Endoscopic retrograde cholangiopancreatography in children. Arch Dis Child 1982; 57:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4822/abstract/5\">",
"      Kunitomo K, Ming L, Urakami Y, et al. Endoscopic retrograde cholangiopancreatography in pediatric surgical biliary diseases. Tokushima J Exp Med 1988; 35:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4822/abstract/6\">",
"      Buckley A, Connon JJ. The role of ERCP in children and adolescents. Gastrointest Endosc 1990; 36:369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4822/abstract/7\">",
"      Putnam PE, Kocoshis SA, Orenstein SR, Schade RR. Pediatric endoscopic retrograde cholangiopancreatography. Am J Gastroenterol 1991; 86:824.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4822/abstract/8\">",
"      Guelrud M, Mendoza S, Jaen D, et al. ERCP and endoscopic sphincterotomy in infants and children with jaundice due to common bile duct stones. Gastrointest Endosc 1992; 38:450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4822/abstract/9\">",
"      D&iacute;t&egrave; P, Vacek E, Stefan H, et al. Endoscopic retrograde cholangiopancreatography in childhood. Hepatogastroenterology 1992; 39:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4822/abstract/10\">",
"      Brown CW, Werlin SL, Geenen JE, Schmalz M. The diagnostic and therapeutic role of endoscopic retrograde cholangiopancreatography in children. J Pediatr Gastroenterol Nutr 1993; 17:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4822/abstract/11\">",
"      Guelrud M, Mujica C, Jaen D, et al. The role of ERCP in the diagnosis and treatment of idiopathic recurrent pancreatitis in children and adolescents. Gastrointest Endosc 1994; 40:428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4822/abstract/12\">",
"      Brown KO, Goldschmiedt M. Endoscopic therapy of biliary and pancreatic disorders in children. Endoscopy 1994; 26:719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4822/abstract/13\">",
"      Lemmel T, Hawes R, Sherman S, et al. Endoscopic evaluation and therapy of recurrent pancreatitis and pancreaticobiliary pain in the pediatric population (abstract). Gastrointest Endosc 1994; 40:A54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4822/abstract/14\">",
"      Portwood G, Maniatis A, Jowell PS, et al. Diagnostic and therapeutic ERCP in children: Safe with a high success rate in experienced hands (abstract). Gastrointest Endosc 1995; 41:A342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4822/abstract/15\">",
"      Abu-Khalaf A. The role of endoscopic retrograde cholangiopancreatography in small children and adolescents (abstract). Surg Laparosc Endosc 1995; 4:296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4822/abstract/16\">",
"      Manegold BC, Gottstein T, Pescatore P. Diagnostic and therapeutic ERCP in children under 14 years (abstract). Gastrointest Endosc 1996; 43:A328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4822/abstract/17\">",
"      Su AY, Hernandez EJ, Brown K, et al. Therapeutic endoscopic retrograde cholangiopancreatography in children (abstract). Gastrointest Endosc 1996; 43:A330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4822/abstract/18\">",
"      Tagge EP, Tarnasky PR, Chandler J, et al. Multidisciplinary approach to the treatment of pediatric pancreaticobiliary disorders. J Pediatr Surg 1997; 32:158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4822/abstract/19\">",
"      Graham KS, Ingram JD, Steinberg SE, Narkewicz MR. ERCP in the management of pediatric pancreatitis. Gastrointest Endosc 1998; 47:492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4822/abstract/20\">",
"      G&uuml;itr&oacute;n A, Adalid R, Barinagarrementer&iacute;a R, et al. [Endoscopic cholangiopancreatography (ERCP) in pediatric patients]. Rev Gastroenterol Mex 1998; 63:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4822/abstract/21\">",
"      Hsu RK, Draganov P, Leung JW, et al. Therapeutic ERCP in the management of pancreatitis in children. Gastrointest Endosc 2000; 51:396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4822/abstract/22\">",
"      Reinshagen K, M&uuml;ldner A, Manegold B, K&auml;hler G. Efficacy of ERCP in infancy and childhood. Klin Padiatr 2007; 219:271.",
"     </a>",
"    </li>",
"    <li>",
"     Guelrud M, Carr-Locke D, Fox VL. ERCP in Pediatric Practice: Diagnosis and Treatment. Oxford, UK: Isis Medical Media Ltd, 1997.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4822/abstract/24\">",
"      Heyman MB, Shapiro HA, Thaler MM. Endoscopic retrograde cholangiography in the diagnosis of biliary malformations in infants. Gastrointest Endosc 1988; 34:449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4822/abstract/25\">",
"      Guelrud M, Jaen D, Mendoza S, et al. ERCP in the diagnosis of extrahepatic biliary atresia. Gastrointest Endosc 1991; 37:522.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4822/abstract/26\">",
"      Wilkinson ML, Mieli-Vergani G, Ball C, et al. Endoscopic retrograde cholangiopancreatography in infantile cholestasis. Arch Dis Child 1991; 66:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4822/abstract/27\">",
"      Derkx HH, Huibregtse K, Taminiau JA. The role of endoscopic retrograde cholangiopancreatography in cholestatic infants. Endoscopy 1994; 26:724.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4822/abstract/28\">",
"      Mitchell SA, Wilkinson ML. The role of ERCP in the diagnosis of neonatal conjugated hyperbilirubinemia (abstract). Gastrointest Endosc 1994; 40:A55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4822/abstract/29\">",
"      Ohnuma N, Takahashi T, Tanabe M, et al. The role of ERCP in biliary atresia. Gastrointest Endosc 1997; 45:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4822/abstract/30\">",
"      Iinuma Y, Narisawa R, Iwafuchi M, et al. The role of endoscopic retrograde cholangiopancreatography in infants with cholestasis. J Pediatr Surg 2000; 35:545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4822/abstract/31\">",
"      Varadarajulu S, Wilcox CM, Hawes RH, Cotton PB. Technical outcomes and complications of ERCP in children. Gastrointest Endosc 2004; 60:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4822/abstract/32\">",
"      Cheng CL, Fogel EL, Sherman S, et al. Diagnostic and therapeutic endoscopic retrograde cholangiopancreatography in children: a large series report. J Pediatr Gastroenterol Nutr 2005; 41:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4822/abstract/33\">",
"      Vegting IL, Tabbers MM, Taminiau JA, et al. Is endoscopic retrograde cholangiopancreatography valuable and safe in children of all ages? J Pediatr Gastroenterol Nutr 2009; 48:66.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4822/abstract/34\">",
"      Iqbal CW, Baron TH, Moir CR, Ishitani MB. Post-ERCP pancreatitis in pediatric patients. J Pediatr Gastroenterol Nutr 2009; 49:430.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5870 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-200.215.4.194-6EBEB1F6CE-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_45_4822=[""].join("\n");
var outline_f4_45_4822=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H22754173\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATIENT PREPARATION AND SEDATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ANTIBIOTIC PROPHYLAXIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      ENDOSCOPIC EQUIPMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      TECHNIQUE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22754217\">",
"      Endoscope insertion and position",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22754210\">",
"      Cannulation of the papilla",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22754239\">",
"      Monitoring",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      SUCCESS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22754173\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/25/41367?source=related_link\">",
"      Antibiotic prophylaxis for gastrointestinal endoscopic procedures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/3/20536?source=related_link\">",
"      ERCP for biliary disease in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/33/24088?source=related_link\">",
"      ERCP for pancreatic disease in children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f4_45_4823="Lepirudin: Drug information";
var content_f4_45_4823=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Lepirudin: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?19/63/20468?source=see_link\">",
"    see \"Lepirudin: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F187207\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Refludan&reg; [DSC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F187208\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Refludan&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F187238\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Anticoagulant, Thrombin Inhibitor",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F187210\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Maximum infusion dose: Do not exceed 0.21 mg/kg/hour unless an evaluation of coagulation abnormalities limiting response has been completed. Bolus doses may increase the risk of bleeding; consider omitting or reducing dose in certain populations.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Heparin-induced thrombocytopenia:",
"     </b>",
"     Bolus dose: 0.4 mg/kg IVP (over 15-20 seconds), followed by continuous infusion at 0.15 mg/kg/hour (maximum initial bolus dose: 44 mg; maximum initial infusion dose: 16.5 mg/hour); bolus and infusion must be reduced in renal insufficiency",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     <b>",
"      or",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Alternate dosing regimen (unlabeled dose; Selleng, 2007; Linkins, 2012): Bolus dose: 0.2 mg/kg (use only if life- or limb-threatening thrombosis present) followed by continuous infusion of 0.05-0.1 mg/kg/hour. Further dosage reduction may be required in patients with renal dysfunction. This alternate dosing regimen has been recommended due to higher rates of bleeding associated with the FDA-approved dosing regimen.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Concomitant use with thrombolytic therapy:",
"     </b>",
"     I.V.: Bolus dose: 0.2 mg/kg IVP (over 15-20 seconds), followed by continuous infusion at 0.1 mg/kg/hour",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Dosing adjustments during infusions:",
"     </b>",
"     Monitor first aPTT 4 hours after the start of the infusion. Subsequent determinations of aPTT should be obtained at least once daily during treatment. More frequent monitoring is recommended in renally- or hepatically-impaired patients. Any aPTT ratio measurement out of range (1.5-2.5) should be confirmed prior to adjusting dose, unless a clinical need for immediate reaction exists. If the aPTT is below target range, increase infusion by 20%. If the aPTT is in excess of the target range, stop infusion for 2 hours and when restarted the infusion rate should be decreased by 50%. A repeat aPTT should be obtained 4 hours after any dosing change.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Transition to oral anticoagulants:",
"     </b>",
"     Once platelets normalize, reduce lepirudin dose gradually to reach aPTT ratio just above 1.5 before starting warfarin therapy. Monitor PT/INR closely until results stabilize in therapeutic range. When lepirudin is discontinued, there may be a small reduction in INR.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F187211\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F187212\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     All patients with a creatinine clearance of &lt;60 mL/minute or a serum creatinine of &gt;1.5 mg/dL require dosage reduction. An alternate dosing regimen has also been recommended for patients with serum creatinine &gt;1 mg/dL (Linkins, 2012). There is only limited information on the therapeutic use of lepirudin in patients with HIT and significant renal impairment; the following dosage recommendations are mainly based on single-dose studies in a small number of patients with renal impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Initial: Bolus dose: 0.2 mg/kg IVP (over 15-20 seconds), followed by adjusted infusion based on renal function; refer to the following infusion rate adjustments based on creatinine clearance (mL/minute) and serum creatinine (mg/dL):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     Acute renal failure or hemodialysis: Infusion is to be avoided or stopped. Following the bolus dose, additional bolus doses of 0.1 mg/kg may be administered every other day only if aPTT falls below lower therapeutic limit (1.5-times patient baseline [or mean laboratory] aPTT).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Lepirudin infusion rates in patients with renal impairment:",
"     </b>",
"     See tables.",
"    </p>",
"    <table border=\"1\" frame=\"border\" rules=\"all\">",
"     <caption style=\"text-align:center;\">",
"      Lepirudin Infusion Rates in Patients With Renal Impairment",
"     </caption>",
"     <col align=\"center\" width=\"125\">",
"     </col>",
"     <col align=\"center\" width=\"100\">",
"     </col>",
"     <col align=\"center\" width=\"100\">",
"     </col>",
"     <col align=\"center\" width=\"100\">",
"     </col>",
"     <thead valign=\"middle\">",
"      <tr>",
"       <th align=\"center\" rowspan=\"2\">",
"        <p style=\"text-indent:0em;\">",
"         Creatinine Clearance",
"        </p>",
"        <p style=\"text-indent:0em;\">",
"         (mL/min)",
"        </p>",
"       </th>",
"       <th align=\"center\" rowspan=\"2\">",
"        <p style=\"text-indent:0em;\">",
"         Serum Creatinine",
"        </p>",
"        <p style=\"text-indent:0em;\">",
"         (mg/dL)",
"        </p>",
"       </th>",
"       <th align=\"center\" colspan=\"2\">",
"        <p style=\"text-indent:0em;\">",
"         Adjusted Infusion Rate",
"        </p>",
"       </th>",
"      </tr>",
"      <tr>",
"       <th align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         % of Standard Initial Infusion Rate",
"        </p>",
"       </th>",
"       <th align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         mg/kg/h",
"        </p>",
"       </th>",
"      </tr>",
"     </thead>",
"     <tbody valign=\"middle\">",
"      <tr>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         45-60",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         1.6-2.0",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         50%",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         0.075",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         30-44",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         2.1-3.0",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         30%",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         0.045",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         15-29",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         3.1-6.0",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         15%",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         0.0225",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         &lt;15",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         &gt;6.0",
"        </p>",
"       </td>",
"       <td align=\"center\" colspan=\"2\">",
"        <p style=\"text-indent:0em;\">",
"         <b>",
"          <i>",
"           Avoid or STOP infusion",
"          </i>",
"         </b>",
"        </p>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"    <table border=\"1\" frame=\"border\" rules=\"all\">",
"     <caption style=\"text-align:center;\">",
"      Alternate Dosing Regimen for Renal Impairment (based on",
"      <i>",
"       Chest",
"      </i>",
"      2012 guidelines",
"      <sup>",
"       1,2",
"      </sup>",
"      )",
"     </caption>",
"     <col align=\"center\" width=\"150\">",
"     </col>",
"     <col align=\"center\" width=\"150\">",
"     </col>",
"     <col align=\"center\" width=\"150\">",
"     </col>",
"     <thead valign=\"middle\">",
"      <tr>",
"       <th align=\"center\" rowspan=\"2\">",
"        <p style=\"text-indent:0em;\">",
"         Serum Creatinine",
"        </p>",
"        <p style=\"text-indent:0em;\">",
"         (mg/dL)",
"        </p>",
"       </th>",
"       <th align=\"center\" colspan=\"2\">",
"        <p style=\"text-indent:0em;\">",
"         Adjusted Infusion Rate",
"        </p>",
"       </th>",
"      </tr>",
"      <tr>",
"       <th align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         % of Standard Initial Infusion Rate",
"         <sup>",
"          3",
"         </sup>",
"        </p>",
"       </th>",
"       <th align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         mg/kg/h",
"        </p>",
"       </th>",
"      </tr>",
"     </thead>",
"     <tfoot valign=\"top\">",
"      <tr>",
"       <td align=\"left\" colspan=\"3\">",
"        <p style=\"text-indent:0em;\">",
"         <sup>",
"          1",
"         </sup>",
"         Recommendation based on low or very low-quality evidence.",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\" colspan=\"3\">",
"        <p style=\"text-indent:0em;\">",
"         <sup>",
"          2",
"         </sup>",
"         In patients with renal insufficiency, the American College of Chest Physicians suggests the use of argatroban instead of lepirudin (Linkins, 2012).",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\" colspan=\"3\">",
"        <p style=\"text-indent:0em;\">",
"         <sup>",
"          3",
"         </sup>",
"         Recommended standard initial infusion rate: 0.1 mg/kg/hour",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\" colspan=\"3\">",
"        <p style=\"text-indent:0em;\">",
"         <sup>",
"          4",
"         </sup>",
"         Recommendation based on manufacturer's labeling.",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\" colspan=\"3\">",
"        <p style=\"text-indent:0em;\">",
"         <b>",
"          Note:",
"         </b>",
"         The initial bolus should either be omitted, or in the case of perceived life- or limb-threatening thrombosis, be given at a reduced dose of 0.2 mg/kg.",
"        </p>",
"       </td>",
"      </tr>",
"     </tfoot>",
"     <tbody valign=\"middle\">",
"      <tr>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         1.0-1.6",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         50%",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         0.05",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         1.7-4.5",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         10%",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         0.01",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         &gt;4.5-6.0",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         5%",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         0.005",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         &gt;6.0",
"        </p>",
"       </td>",
"       <td align=\"center\" colspan=\"2\">",
"        <p style=\"text-indent:0em;\">",
"         <b>",
"          <i>",
"           Avoid or STOP infusion",
"           <sup>",
"            4",
"           </sup>",
"          </i>",
"         </b>",
"        </p>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F16160283\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F187190\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, powder for reconstitution:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Refludan&reg;: 50 mg [DSC]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F187175\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F15252618\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Not available in the U.S.",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F187193\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Administer",
"     <b>",
"      only",
"     </b>",
"     intravenously; administer I.V. bolus over 15-20 seconds",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F6108344\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in D",
"     <sub>",
"      5",
"     </sub>",
"     W, NS.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Y-site administration: Visually compatible",
"     </b>",
"     (Chalmers, 2001): Amiodarone.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F187192\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Indicated for anticoagulation in patients with heparin-induced thrombocytopenia (HIT) and associated thromboembolic disease in order to prevent further thromboembolic complications",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F5174556\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      High alert medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       The Institute for Safe Medication Practices (ISMP) includes this medication among its list of drugs which have a heightened risk of causing significant patient harm when used in error.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F187236\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     As with all anticoagulants, bleeding is the most common adverse event associated with lepirudin. Hemorrhage may occur at virtually any site. Risk is dependent on multiple variables.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      HIT patients:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &gt;10%: Hematologic: Anemia (12%), bleeding from puncture sites (11%), hematoma (11%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Heart failure (3%), pericardial effusion (1%), ventricular fibrillation (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Fever (7%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Maculopapular rash (4%), eczema (3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: GI bleeding/rectal bleeding (5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Genitourinary: Vaginal bleeding (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hepatic: Transaminases increased (6%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Renal: Hematuria (4%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Epistaxis (4%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1% (Limited to important or life-threatening): Allergic reactions, anaphylaxis, hemoperitoneum, hemoptysis, injection site reactions, intracranial bleeding, liver bleeding, mouth bleeding, pruritus, pulmonary bleeding, retroperitoneal bleeding, thrombocytopenia, urticaria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Non-HIT populations",
"     </b>",
"     (including those receiving thrombolytics and/or contrast media):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%: Respiratory: Bronchospasm/stridor/dyspnea/cough",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1% (Limited to important or life-threatening): Allergic reactions (unspecified), anaphylactoid reactions, anaphylaxis, angioedema, intracranial bleeding (0.6%), laryngeal edema, thrombocytopenia, tongue edema",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F187196\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to hirudins or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F187179\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Anaphylaxis/hypersensitivity reactions: Allergic and hypersensitivity reactions, including anaphylaxis have been reported. Be cautious in re-exposing patients (anaphylaxis has been reported).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Bleeding: The most common complication is bleeding. Certain patients are at increased risk of bleeding; risk factors include bacterial endocarditis; congenital or acquired bleeding disorders; recent puncture of large vessels or organ biopsy; recent CVA, stroke, intracerebral surgery, or other neuraxial procedure; severe uncontrolled hypertension; renal impairment; recent major surgery; recent major bleeding (intracranial, GI, intraocular, or pulmonary). Monitor for signs and symptoms of bleeding.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cirrhosis: Use with caution in patients with cirrhosis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with renal impairment, relative overdose might occur even with standard dosage regimen. The bolus dose and rate of infusion must be reduced in patients with known or suspected renal insufficiency.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Thrombolytic episode: Cautiously administer after a thrombolytic episode; risk of intracranial bleeding.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Streptokinase: Allergic reactions may occur frequently in patients treated concomitantly with streptokinase.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pediatrics: Safety and efficacy have not been established in children.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Monitoring: Strict monitoring of aPTT is required; formation of antihirudin antibodies can increase the anticoagulant effect of lepirudin.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299582\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F187184\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Agents with Antiplatelet Properties (e.g., P2Y12 inhibitors, NSAIDs, SSRIs, etc.): May enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticoagulants: May enhance the anticoagulant effect of other Anticoagulants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Apixaban: May enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Collagenase (Systemic): Anticoagulants may enhance the adverse/toxic effect of Collagenase (Systemic). Specifically, the risk of injection site bruising and/or bleeding may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dabigatran Etexilate: May enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dasatinib: May enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: Anticoagulants may enhance the adverse/toxic effect of Deferasirox. Specifically, the risk for GI ulceration/irritation or GI bleeding may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (Anticoagulant/Antiplatelet Properties) (eg, Alfalfa, Anise, Bilberry): May enhance the adverse/toxic effect of Anticoagulants. Bleeding may occur.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ibritumomab: Anticoagulants may enhance the adverse/toxic effect of Ibritumomab. Both agents may contribute to an increased risk of bleeding.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nonsteroidal Anti-Inflammatory Agents: May enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Omacetaxine: Anticoagulants may enhance the adverse/toxic effect of Omacetaxine. Specifically, the risk for bleeding-related events may be increased.  Management: Avoid concurrent use of anticoagulants with omacetaxine in patients with a platelet count of less than 50,000/uL.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Omega-3 Fatty Acids: May enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pentosan Polysulfate Sodium: May enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Prostacyclin Analogues: May enhance the adverse/toxic effect of Anticoagulants. Specifically, the antiplatelet effects of these agents may lead to an increased risk of bleeding with the combination.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rivaroxaban: Anticoagulants may enhance the anticoagulant effect of Rivaroxaban.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Salicylates: May enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thrombolytic Agents: May enhance the anticoagulant effect of Anticoagulants. Management: See full drug monograph for guidelines for the use of alteplase for acute ischemic stroke during treatment with oral anticoagulants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tipranavir: May enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tositumomab and Iodine I 131 Tositumomab: Anticoagulants may enhance the adverse/toxic effect of Tositumomab and Iodine I 131 Tositumomab. Specifically, the risk of bleeding-related adverse effects may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin E: May enhance the anticoagulant effect of Anticoagulants. Vitamin E may also increase the overall risk for bleeding.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F187204\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Herb/Nutraceutical: Avoid cat's claw, dong quai, evening primrose, feverfew, garlic, ginger, ginkgo, red clover, horse chestnut, green tea, ginseng (all have additional antiplatelet activity)",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F187186\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F187198\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events were not observed in animal reproduction studies. Data are insufficient to evaluate the safety of thrombin inhibitors during pregnancy. Use of parenteral thrombin inhibitors in pregnancy should be limited to those women who have severe allergic reactions to heparin, including heparin induced thrombocytopenia, and who cannot receive danaparoid (Guyatt, 2012).",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F187217\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion unknown/not recommended",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F14080809\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     A case report describes lepirudin use in a breast-feeding woman, 7 weeks postpartum. The mother was using lepirudin 50 mg twice daily. Maternal serum concentrations were 0.73 mg/L and milk concentrations were below the limit of detection (0.1 mg/L) when measured 3 hours after administration (Lindhoff-Last, 2000).",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F187188\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Monitor aPTT levels; obtain baseline aPTT, then monitor first aPTT 4 hours after the start of the infusion and every 4 hours until steady state is reached (2 consecutive aPTTs in the same range) (Linkins, 2012). Subsequent determinations of aPTT should be obtained at least once daily during treatment. More frequent monitoring is recommended in renally- or hepatically-impaired patients. Any aPTT ratio measurement out of range (1.5-2.5) should be confirmed prior to adjusting dose, unless a clinical need for immediate reaction exists",
"    </p>",
"   </div>",
"   <div class=\"block rer drugH1Div\" id=\"F187191\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reference Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     aPTT 1.5 to 2.5 times the control value",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F187199\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Refludan (AT, AU, BE, BG, CH, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HN, HU, IE, IT, KP, MT, NL, NO, PL, PT, RU, SE, SK, TR)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F187178\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Lepirudin is a highly specific direct inhibitor of thrombin; lepirudin is a recombinant hirudin derived from yeast cells",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F187195\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: Two-compartment model; confined to extracellular fluids",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Via release of amino acids via catabolic hydrolysis of parent drug",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: Initial: ~10 minutes: Terminal: Healthy volunteers: 1.3 hours; Marked renal impairment (Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;15 mL/minute and on hemodialysis): &le;2 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (~48%, 35% as unchanged drug and unchanged drug fragments of parent drug); systemic clearance is proportional to glomerular filtration rate or creatinine clearance",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Chalmers JR, Bobek MB, and Militello MA, &ldquo;Visual Compatibility of Amiodarone Hydrochloride Injection With Various Intravenous Drugs,&rdquo;",
"      <i>",
"       Am J Health Syst Pharm",
"      </i>",
"      , 2001, 58(6):504-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?4/45/4823/abstract-text/11286148/pubmed\" id=\"11286148\" target=\"_blank\">",
"        11286148",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Eichler P, Friesen HJ, Lubenow N, et al, &ldquo;Antihirudin Antibodies in Patients With Heparin-Induced Thrombocytopenia Treated With Lepirudin: Incidence, Effects on aPTT, and Clinical Relevance,&rdquo;",
"      <i>",
"       Blood",
"      </i>",
"      , 2000, 96(7):2373-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?4/45/4823/abstract-text/11001886/pubmed\" id=\"11001886\" target=\"_blank\">",
"        11001886",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Guyatt GH, Akl EA, Crowther M, et al, &ldquo;Executive Summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines,&rdquo;",
"      <i>",
"       Chest",
"      </i>",
"      , 2012, 141(2 Suppl):7-47.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?4/45/4823/abstract-text/22315257/pubmed\" id=\"22315257\" target=\"_blank\">",
"        22315257",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hirsh J, Guyatt G, Albers GW, et al, &ldquo;Executive Summary: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition),&rdquo;",
"      <i>",
"       Chest",
"      </i>",
"      , 2008, 133(6 Suppl):71-109.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?4/45/4823/abstract-text/18574259/pubmed\" id=\"18574259\" target=\"_blank\">",
"        18574259",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hule G, Hoffman U, Hoffman I, et al, \"A New Therapeutic Option by Subcutaneous Hirudin in Patients With Heparin-Induced Thrombocytopenia Type II: A Pilot Study,\"",
"      <i>",
"       Thrombosis Res",
"      </i>",
"      , 2000, 99:325-34.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lindhoff-Last E, Willeke A, Thalhammer C, et al, &ldquo;Hirudin Treatment in a Breastfeeding Woman,&rdquo;",
"      <i>",
"       Lancet",
"      </i>",
"      , 2000, 355(9202):467-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?4/45/4823/abstract-text/10841132/pubmed\" id=\"10841132\" target=\"_blank\">",
"        10841132",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Linkins L, Dans AL, Moores LK, et al, &ldquo;Treatment and Prevention of Heparin-Induced Thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines,&rdquo;",
"      <i>",
"       Chest",
"      </i>",
"      , 2012, 141(2 Suppl):e495-530.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?4/45/4823/abstract-text/22315270/pubmed\" id=\"22315270\" target=\"_blank\">",
"        22315270",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Liu H. Fleming NW, and Moore PG, &ldquo;Anticoagulation for Patients With Heparin-Induced Thrombocytopenia Using Recombinant Hirudin During Cardiopulmonary Bypass,&rdquo;",
"      <i>",
"       J Clin Anesth",
"      </i>",
"      , 2002, 14(6):452-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?4/45/4823/abstract-text/12393116/pubmed\" id=\"12393116\" target=\"_blank\">",
"        12393116",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lubenow N, Eichler P, Lietz T, et al, &ldquo;Lepirudin in Patients With Heparin-Induced Thrombocytopenia-Results of the Third Prospective Study (HAT-3) and a Combined Analysis of HAT-1. HAT-2, and HAT-3,&rdquo;",
"      <i>",
"       J Thromb Haemost",
"      </i>",
"      , 2005, 3(11):2428-36.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?4/45/4823/abstract-text/16241940/pubmed\" id=\"16241940\" target=\"_blank\">",
"        16241940",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Pinto DS, Sperling RT, Tu TM, et al, &ldquo;Combination Platelet Glycoprotein IIb/IIIa Receptor and Lepirudin Administration During Percutaneous Coronary Intervention in Patients With Heparin-Induced Thrombocytopenia,&rdquo;",
"      <i>",
"       Catheter Cardiovasc Interv",
"      </i>",
"      , 2003, 58(1):65-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?4/45/4823/abstract-text/12508198/pubmed\" id=\"12508198\" target=\"_blank\">",
"        12508198",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Schiele F, Lindgaerde F, Eriksson H, et al, \"Subcutaneous Recombinant Hirudin (HBW 023) Versus Intravenous Sodium Heparin in Treatment of Established Acute Deep Vein Thrombosis of the Legs: A Multicentre Prospective Dose-Ranging Randomized Trial. International Multicentre Hirudin Study Group,\"",
"      <i>",
"       Thromb Haemost",
"      </i>",
"      , 1997, 77(5):834-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?4/45/4823/abstract-text/9184388/pubmed\" id=\"9184388\" target=\"_blank\">",
"        9184388",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Selleng K, Warkentin TE, Greinacher A, &ldquo;Heparin-Induced Thrombocytopenia in Intensive Care Patients,&rdquo;",
"      <i>",
"       Crit Care Med",
"      </i>",
"      , 2007, 35(4):1165-76.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?4/45/4823/abstract-text/17334253/pubmed\" id=\"17334253\" target=\"_blank\">",
"        17334253",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9844 Version 39.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-60.18.131.125-6AD27EA953-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_45_4823=[""].join("\n");
var outline_f4_45_4823=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187207\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187208\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187238\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187210\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187211\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187212\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16160283\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187190\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187175\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15252618\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187193\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6108344\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187192\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5174556\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187236\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187196\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187179\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299582\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187184\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187204\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187186\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187198\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187217\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14080809\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187188\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187191\">",
"      Reference Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187199\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187178\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187195\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9844\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9844|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?19/63/20468?source=related_link\">",
"      Lepirudin: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f4_45_4824="Lymphomatoid granuloma Low";
var content_f4_45_4824=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F74089&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F74089&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Lymphomatoid granulomatosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 392px; height: 294px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Low magnification photomicrograph (original magnification 100x) illustrating zone of necrosis surrounded by a lymphocytic infiltrate with conspicuous vascular infiltration (right).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_45_4824=[""].join("\n");
var outline_f4_45_4824=null;
var title_f4_45_4825="Normal optic disc 2";
var content_f4_45_4825=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F54781%7ENEURO%2F59423%7ENEURO%2F72175&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F54781%7ENEURO%2F59423%7ENEURO%2F72175&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Normal optic disc Grade 0",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 450px; height: 364px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Michael Wall, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Optic disc Fris&eacute;n Grade II",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 450px; height: 354px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Fris&eacute;n Grade II showing the halo of disc edema is circumferential.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Michael Wall, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Optic disc Fris&eacute;n Grade III",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 450px; height: 350px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Fris&eacute;n Grade 3 showing obscuration of a major vessel as it leaves the optic disc (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Michael Wall, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_45_4825=[""].join("\n");
var outline_f4_45_4825=null;
var title_f4_45_4826="Epiglottitis (supraglottitis): Clinical features and diagnosis";
var content_f4_45_4826=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Epiglottitis (supraglottitis): Clinical features and diagnosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/45/4826/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/45/4826/contributors\">",
"     Charles R Woods, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/45/4826/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/45/4826/contributors\">",
"     Morven S Edwards, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/45/4826/contributors\">",
"     Glenn C Isaacson, MD, FAAP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/45/4826/contributors\">",
"     Gary R Fleisher, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/45/4826/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/45/4826/contributors\">",
"     James F Wiley, II, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?4/45/4826/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 14, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathogenesis, etiology, and clinical features of epiglottitis (also called supraglottitis) will be reviewed here. The treatment and prevention of epiglottitis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/16/12553?source=see_link\">",
"     \"Epiglottitis (supraglottitis): Treatment and prevention\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Epiglottitis is inflammation of the epiglottis and adjacent supraglottic structures [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/1\">",
"     1",
"    </a>",
"    ]. Without treatment, epiglottitis can progress to life-threatening airway obstruction. A rapid overview of the recognition and management of epiglottitis in children is provided in the table (",
"    <a class=\"graphic graphic_table graphicRef80169 \" href=\"UTD.htm?25/10/25773\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ANATOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The epiglottis forms the back wall of the vallecular space below the base of the tongue (",
"    <a class=\"graphic graphic_figure graphicRef74538 \" href=\"UTD.htm?1/54/1894\">",
"     figure 1",
"    </a>",
"    ). It is connected to the thyroid cartilage and hyoid bone by ligaments. The epiglottis consists of a thin cartilage that is covered anteriorly by a stratified squamous epithelial layer. This squamous layer also covers the superior third of the posterior surface, where it merges with respiratory epithelium that extends into the larynx. The squamous epithelial layer is loosely adherent to the cartilage, creating a large potential space.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infectious epiglottitis is a cellulitis of the epiglottis, aryepiglottic folds, and other adjacent tissues. It results from bacteremia",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    direct invasion of the epithelial layer by the pathogenic organism [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. The posterior nasopharynx is the primary source of pathogens in epiglottitis. Microscopic trauma to the epithelial surface (eg, mucosal damage during a viral infection or from food during swallowing) may be a predisposing factor.",
"   </p>",
"   <p>",
"    Swelling of the epiglottis results from edema and accumulation of inflammatory cells in the potential space between the squamous epithelial layer and the epiglottal cartilage. Swelling rapidly progresses to involve the entire supraglottic larynx (including the aryepiglottic folds and arytenoids) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/3\">",
"     3",
"    </a>",
"    ]. The subglottic regions generally are not affected; swelling is halted by the tightly bound epithelium at the level of the vocal cords.",
"   </p>",
"   <p>",
"    Supraglottic swelling reduces the caliber of the airway, causing turbulent airflow during inspiration (stridor) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/3\">",
"     3",
"    </a>",
"    ]. Additional mechanisms of airflow obstruction may include posterior and inferior curling of the epiglottis (which acts as ball-valve, obstructing airflow during inspiration but permitting exhalation) and aspiration of oropharyngeal secretions [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Airway obstruction, which may result in cardiopulmonary arrest, can be rapidly progressive. The signs of severe upper airway obstruction (eg,",
"    <span class=\"nowrap\">",
"     stridor/stertor,",
"    </span>",
"    intercostal and suprasternal retraction, tachypnea, and cyanosis) may be absent until late in the disease process, when airway obstruction is nearly complete [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/4,5\">",
"     4,5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Infectious causes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Epiglottitis may be caused by a number of bacterial, viral, and fungal pathogens (",
"    <a class=\"graphic graphic_table graphicRef54481 \" href=\"UTD.htm?7/29/7644\">",
"     table 2",
"    </a>",
"    ). In previously healthy children, most cases are bacterial. The most frequent pathogens vary depending upon patient age and immune status.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Children &ndash; Haemophilus influenzae type b (Hib) is the most common infectious cause of epiglottitis in children. Although the incidence of Hib epiglottitis declined after Hib was added to the routine infant immunization schedule in the United States and other developed countries, Hib epiglottitis still occurs, even in immunized children [",
"      <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/6-10\">",
"       6-10",
"      </a>",
"      ]. In a case series from a single institution, Hib accounted for 6 of 19 cases between 1992 and 2002; five of the cases occurred in children who had been fully immunized [",
"      <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/6\">",
"       6",
"      </a>",
"      ]. Additional causes of epiglottitis in children include other H. influenzae (types A, F, and nontypeable), streptococci, and Staphylococcus aureus (",
"      <a class=\"graphic graphic_table graphicRef54481 \" href=\"UTD.htm?7/29/7644\">",
"       table 2",
"      </a>",
"      ), including methicillin-resistant strains [",
"      <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/11\">",
"       11",
"      </a>",
"      ]. Group A streptococcal epiglottitis complicating primary varicella has also been reported [",
"      <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/12\">",
"       12",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Adults &ndash; In adults, epiglottitis has been associated with a broad range of bacteria, viruses, combined viral-bacterial infections fungi, and noninfectious causes (",
"      <a class=\"graphic graphic_table graphicRef54481 \" href=\"UTD.htm?7/29/7644\">",
"       table 2",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/4\">",
"       4",
"      </a>",
"      ]. In most cases, blood and throat cultures are negative [",
"      <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/10,13,14\">",
"       10,13,14",
"      </a>",
"      ]. However, among cases in which a pathogen is identified, Hib is most common, accounting for 3 to 14 percent of all cases [",
"      <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/10,13-16\">",
"       10,13-16",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Immunocompromised hosts &ndash; In immunocompromised hosts, epiglottitis may be caused by Pseudomonas aeruginosa and Candida species [",
"      <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/17-19\">",
"       17-19",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Noninfectious causes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Traumatic causes of epiglottitis include thermal injury, foreign body ingestion, and caustic ingestion [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/20-24\">",
"     20-24",
"    </a>",
"    ]. Epiglottitis also may rarely occur as a complication of bone marrow or solid organ transplantation (eg, as a manifestation of post-transplant lymphoproliferative disease or graft-versus-host disease) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/25,26\">",
"     25,26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Incidence and median age",
"    </span>",
"    &nbsp;&mdash;&nbsp;The epidemiology of epiglottitis changed after the addition of the Hib conjugate vaccine to the routine infant immunization schedule in the United States and other developed countries [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/27-34\">",
"     27-34",
"    </a>",
"    ]. Important changes included:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A decrease in the average annual incidence of epiglottitis in children.",
"     </li>",
"     <li>",
"      An increase in the median age of children with epiglottitis from 3 years of age to approximately 6 to 12 years of age [",
"      <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/6,35\">",
"       6,35",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The annual incidence of epiglottitis among children declined dramatically after introduction of vaccines against Hib. In the US the annual rate of epiglottitis prior to the availability of Hib vaccines was approximately 5 per 100,000 children ages &le;5 yrs old [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/2\">",
"     2",
"    </a>",
"    ]. Among immunized children in some populations, estimates of epiglottis rates have ranged from 0.6 to 0.8 cases per 100,000 [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/4,7\">",
"     4,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Additional studies suggest even greater overall declines in epiglottitis in immunized children over time:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The rate of epiglottitis in children in Roskilde County, Denmark fell from 4.9 per 100,000",
"      <span class=\"nowrap\">",
"       children/year",
"      </span>",
"      during 1983 to 1992 to 0.02 per 100,000",
"      <span class=\"nowrap\">",
"       children/year",
"      </span>",
"      between 1996 and 2005 [",
"      <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/30\">",
"       30",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Following introduction of Hib vaccine in 1989, no cases of epiglottitis in children &lt;10 yrs old were diagnosed in Iceland between 1990 and 2005 [",
"      <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/36\">",
"       36",
"      </a>",
"      ]. The overall incidence of epiglottitis in Icelandic children (&lt;18 yrs old) was 0.76 per 100,000",
"      <span class=\"nowrap\">",
"       children/year",
"      </span>",
"      in the pre-Hib-vaccine era and fell to 0.071 in the post-vaccine era.",
"     </li>",
"     <li>",
"      Similarly, the frequency of epiglottitis at the Children&rsquo;s Hospital of Philadelphia declined from 10.9 per 10,000 admissions during 1979 to 1989 to 1.8 during 1990 to 1992 [",
"      <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/35\">",
"       35",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      At the Children&rsquo;s Hospital of Buffalo, the frequency of epiglottitis fell from 3.5 cases per 10,000 admissions in 1969 to 1977 to 0.3 cases per 10,000 admissions in 1995 to 2003 [",
"      <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/37\">",
"       37",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The incidence of epiglottitis in adults appears largely stable in the past few decades with 0.6 to 1.9",
"    <span class=\"nowrap\">",
"     cases/100,000/year",
"    </span>",
"    in Iceland and Denmark studies, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/30,36\">",
"     30,36",
"    </a>",
"    ]. In the US, cases among adults also remained about the same from 1998 to 2006. There were an estimated 3405 total cases in 2006 among persons &ge;18 yrs old and 369 among children &lt;18 yrs old [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Based upon US adult (&ge;20 yrs old) and pediatric (&lt;20 yrs old) population estimates of 217.4 million and 82 million for 2006 [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/39\">",
"     39",
"    </a>",
"    ], there were about 1.6 cases of epiglottitis per 100,000 adults and 0.5 cases per 100,000 children in the US in 2006.",
"   </p>",
"   <p>",
"    In the pre-Hib-vaccine era in the US, 72 percent of cases of epiglottis occurred in children between the ages of one and five years, with peak occurrence in the third year of life [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/2\">",
"     2",
"    </a>",
"    ]. The median age of children with epiglottitis in one center increased from 36 months during 1979 to 1989 (134 children) to 80 months during 1990 to 1992 (8 children) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/35\">",
"     35",
"    </a>",
"    ]. In another center, the mean ages of 9 children with epiglottis from 1992 to 1997, and 10 children from 1998 to 2002 were 5.8 years and 11.6 years, respectively (P = .008) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/6\">",
"     6",
"    </a>",
"    ]. Epiglottitis historically has been somewhat more common in boys (58 percent) than girls [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;In children, risk factors for epiglottitis include incomplete or lack of immunization for Hib and immune deficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/40-42\">",
"     40-42",
"    </a>",
"    ]. For example, a five year old with epiglottitis as the initial presentation of systemic lupus erythematosus has been described [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/43\">",
"     43",
"    </a>",
"    ]. In addition, some hosts may be genetically more susceptible to invasive Hib infection [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/44-47\">",
"     44-47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In adults, epiglottitis has been associated with a number of comorbid conditions, including hypertension, diabetes mellitus, substance abuse, and immune deficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/13,48-51\">",
"     13,48-51",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Suspected epiglottitis is a medical emergency. To minimize morbidity and mortality, prompt recognition and treatment is critical (",
"    <a class=\"graphic graphic_table graphicRef80169 \" href=\"UTD.htm?25/10/25773\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Presentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The primary objective in the management of patients with epiglottitis is to make a definitive diagnosis and initiate treatment before the onset of airway obstruction [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/3\">",
"     3",
"    </a>",
"    ]. Maintenance of the airway is the focus of treatment. In patients with signs of total or near-total airway obstruction, airway control necessarily precedes diagnostic evaluation [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/16/12553?source=see_link\">",
"     \"Epiglottitis (supraglottitis): Treatment and prevention\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/48/29450?source=see_link\">",
"     \"Emergent endotracheal intubation in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/14/36068?source=see_link\">",
"     \"Advanced emergency airway management in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The clinical features of epiglottitis differ with age, severity, and etiology. Young children classically present with respiratory distress, anxiety, and the characteristic \"tripod\" or \"sniffing\" posture (",
"    <a class=\"graphic graphic_picture graphicRef79826 \" href=\"UTD.htm?25/54/26465\">",
"     picture 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef76538 \" href=\"UTD.htm?8/0/8197\">",
"     picture 2",
"    </a>",
"    ). However, the presentation may be subtle (",
"    <a class=\"graphic graphic_picture graphicRef69055 \" href=\"UTD.htm?1/45/1747\">",
"     picture 3",
"    </a>",
"    ). Older children, adolescents, and adults may present with a severe sore throat but relatively normal oropharyngeal examination.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Children",
"    </span>",
"    &nbsp;&mdash;&nbsp;Abrupt onset and rapid progression (within hours) of dysphagia, drooling, and distress (\"the three D's\") are hallmarks of epiglottitis in children [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/5,52-56\">",
"     5,52-56",
"    </a>",
"    ]. Although many patients have minor antecedent upper respiratory tract symptoms, the usual duration of notable illness before hospitalization is &lt;24 hours and frequently &lt;12 hours.",
"   </p>",
"   <p>",
"    Sudden onset of high fever (between 38.8&ordm; and 40.0&ordm;C), severe sore throat, odynophagia, and drooling is common. Children with epiglottitis usually appear \"toxic\" (",
"    <a class=\"graphic graphic_picture graphicRef76538 \" href=\"UTD.htm?8/0/8197\">",
"     picture 2",
"    </a>",
"    ); however, there is a wide spectrum of severity (",
"    <a class=\"graphic graphic_picture graphicRef69055 \" href=\"UTD.htm?1/45/1747\">",
"     picture 3",
"    </a>",
"    ). They experience a choking sensation, are distressed during inspiration, and are anxious, restless, and irritable. Their speech is muffled, often described as a \"hot potato\" voice [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/5\">",
"     5",
"    </a>",
"    ]. Children with epiglottitis generally lack hoarseness, cough, and stridor until late in the disease process.",
"   </p>",
"   <p>",
"    Children with epiglottitis may assume a sitting position with the trunk leaning forward, neck hyperextended, and chin thrust forward in an effort to maximize the diameter of the obstructed airway (the \"tripod\" posture, (",
"    <a class=\"graphic graphic_picture graphicRef79826 \" href=\"UTD.htm?25/54/26465\">",
"     picture 1",
"    </a>",
"    ))&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/5\">",
"     5",
"    </a>",
"    ]. They may be reluctant to lie down [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a case series of 134 children with epiglottitis from a single state (1975 to 1992), the following findings were documented in the history or physical examination [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/13\">",
"     13",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    Symptoms:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Difficulty breathing (80 percent)",
"     </li>",
"     <li>",
"      Stridor (80 percent)",
"     </li>",
"     <li>",
"      Muffled or hoarse voice (79 percent)",
"     </li>",
"     <li>",
"      Pharyngitis (73 percent)",
"     </li>",
"     <li>",
"      Fever (57 percent)",
"     </li>",
"     <li>",
"      Sore throat (50 percent)",
"     </li>",
"     <li>",
"      Tenderness of anterior neck (38 percent)",
"     </li>",
"     <li>",
"      Cough (30 percent)",
"     </li>",
"     <li>",
"      Difficulty swallowing (26 percent)",
"     </li>",
"     <li>",
"      Change in voice (20 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Adults",
"    </span>",
"    &nbsp;&mdash;&nbsp;Presenting features of epiglottitis in adults include [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/4,13,14,30,57\">",
"     4,13,14,30,57",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Sore throat or odynophagia (90 to 100 percent)",
"     </li>",
"     <li>",
"      Fever &ge;37.5&ordm;C (26 to 90 percent)",
"     </li>",
"     <li>",
"      Muffled voice (50 to 80 percent)",
"     </li>",
"     <li>",
"      Drooling (15 to 65 percent)",
"     </li>",
"     <li>",
"      Stridor or respiratory compromise (approximately 33 percent)",
"     </li>",
"     <li>",
"      Hoarseness (20 to 40 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The progression of symptoms in adults is slower than that in children. In one series of 106 patients, 65 percent presented within two days of symptom onset, but 9 percent presented more than one week later [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a series of 102 children with croup and 101 with epiglottitis in Melbourne, Australia 1980 to 2009, drooling, preferring to sit, refusal to swallow and dysphagia were more common in children with epiglottitis while cough was more common in those with croup [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/58\">",
"     58",
"    </a>",
"    ]. Fever was present in &gt;90 percent of children with epiglottitis, drooling in 80 percent with epiglottitis but &lt;10 percent with croup, and stridor and retractions in &ge;80 percent of both conditions. Cough was noted in &lt;10 percent of children with epiglottitis in this series.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Examination",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Examining children",
"    </span>",
"    &nbsp;&mdash;&nbsp;Examination of a child in whom epiglottitis is a consideration should occur in a setting where the airway can be secured immediately if necessary (eg, the operating room, emergency department, or intensive care unit) (",
"    <a class=\"graphic graphic_table graphicRef80169 \" href=\"UTD.htm?25/10/25773\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Examination efforts should be individualized according to the severity of illness of the child. There are rare reports of cardiorespiratory arrest during attempts to visualize the epiglottis. These arrests have been attributed to functional airway obstruction (resulting from increased respiratory effort secondary to increased anxiety)",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    aggravation of airway obstruction caused by supine positioning.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Moderate or severe distress",
"      </strong>",
"      &ndash; In children with moderate or severe respiratory distress and clinical features of epiglottitis (eg, anxiety, \"sniffing\" (",
"      <a class=\"graphic graphic_picture graphicRef76538 \" href=\"UTD.htm?8/0/8197\">",
"       picture 2",
"      </a>",
"      ), and signs of upper airway involvement, particularly stridor, drooling, or \"tripod\" posture (",
"      <a class=\"graphic graphic_picture graphicRef79826 \" href=\"UTD.htm?25/54/26465\">",
"       picture 1",
"      </a>",
"      )), epiglottitis should be suspected without intraoral examination. The child should be kept as calm as possible and accompanied to the operating room by an experienced anesthetist and surgeon [",
"      <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/1,4\">",
"       1,4",
"      </a>",
"      ]. In the operating room, the epiglottis and supraglottic airway can be assessed via direct laryngoscopy and bronchoscopy, and an artificial airway can be established under controlled circumstances [",
"      <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/1,4\">",
"       1,4",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H28\">",
"       'Diagnosis'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      <strong>",
"       Mild distress",
"      </strong>",
"      &ndash; In children with mild symptoms in whom epiglottitis is a possibility, but for whom other diagnoses are considered to be more likely (",
"      <a class=\"graphic graphic_table graphicRef51465 \" href=\"UTD.htm?39/12/40140\">",
"       table 3",
"      </a>",
"      ), the child may be gently approached in the upright position (preferably sitting on the lap of a parent) and examined with careful application of a tongue blade or indirect laryngoscopy (eg, a mirror examination or flexible nasopharyngoscopy). This examination should occur in a setting where the airway can be secured immediately if necessary (eg, the emergency department, intensive care unit, or operating room, depending upon the degree of distress at presentation).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    As an alternative for children in whom oral examination increases anxiety, lateral neck radiographs may be obtained [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H20\">",
"     'Radiographic features'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Examination findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Examination of the oral cavity and oropharynx in patients with epiglottitis is normal in the majority of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/4,14,59\">",
"     4,14,59",
"    </a>",
"    ]. Pooled secretions may be noted [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/3\">",
"     3",
"    </a>",
"    ]. The laryngotracheal complex may be tender to palpation, particularly in the region of the hyoid bone [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/60-62\">",
"     60-62",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Examination findings consistent with epiglottitis include inflammation and edema of the supraglottic structures (epiglottis, aryepiglottic folds, and arytenoid cartilages) (",
"    <a class=\"graphic graphic_picture graphicRef59738 \" href=\"UTD.htm?5/51/5937\">",
"     picture 4",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/4\">",
"     4",
"    </a>",
"    ]. The false vocal cords also may be involved [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Extra-epiglottic foci",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients should be examined for extra-epiglottic foci of infection (eg, pneumonia, cervical adenitis, cellulitis, septic arthritis, or, less commonly, meningitis), particularly if a pathogen that frequently causes invasive disease at other sites is a possibility (eg, S. pneumoniae, Hib) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/63\">",
"     63",
"    </a>",
"    ]. Additional evaluation for extra-epiglottic infection is guided by clinical findings. (See appropriate topic reviews).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Laboratory features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laboratory studies should not be performed in patients with suspected epiglottitis until the airway is secured. Laboratory evaluation should include complete blood count with differential, blood culture, and epiglottal culture (in intubated patients).",
"   </p>",
"   <p>",
"    Most patients with epiglottitis have an elevated white blood cell count [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/4\">",
"     4",
"    </a>",
"    ], but this finding is nonspecific.",
"   </p>",
"   <p>",
"    The yield of blood and epiglottal cultures is discussed below. (See",
"    <a class=\"local\" href=\"#H33\">",
"     'Microbiology'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The laboratory evaluation for a child who develops Hib epiglottitis or pneumococcal epiglottitis despite having been immunized is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/16/12553?source=see_link&amp;anchor=H23#H23\">",
"     \"Epiglottitis (supraglottitis): Treatment and prevention\", section on 'Additional evaluation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Radiographic features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Soft-tissue lateral neck radiographs can confirm the diagnosis of epiglottitis but are not necessary in many cases. Radiographs are most helpful in the evaluation of children in whom epiglottitis is a possibility but other conditions are more likely (",
"    <a class=\"graphic graphic_table graphicRef51465 \" href=\"UTD.htm?39/12/40140\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Radiographs should be deferred if they increase the child's level of anxiety or will delay definitive diagnosis and management [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/13,34\">",
"     13,34",
"    </a>",
"    ]. If it is necessary for the patient to be transported to the radiology department (ie, if portable radiographs cannot be obtained), the patient must be accompanied by a clinician skilled at airway management.",
"   </p>",
"   <p>",
"    Radiographic features of epiglottitis include [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/2,65\">",
"     2,65",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An enlarged epiglottis protruding from the anterior wall of the hypopharynx (the \"thumb sign\", (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef67312 \" href=\"UTD.htm?41/42/42663\">",
"       image 1",
"      </a>",
"      )). In adults with epiglottitis, the width of the epiglottis is usually &gt;8 mm [",
"      <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/66\">",
"       66",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Loss of the vallecular air space, a finding that may be underappreciated.",
"     </li>",
"     <li>",
"      Thickened aryepiglottic folds (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef67878 \" href=\"UTD.htm?22/26/22958\">",
"       image 2",
"      </a>",
"      ). In adults with epiglottitis, the width of the aryepiglottic folds is usually &gt;7 mm [",
"      <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/66\">",
"       66",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Distended hypopharynx (nonspecific).",
"     </li>",
"     <li>",
"      Straightening or reversal of the normal cervical lordosis (nonspecific).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Hib versus non-Hib",
"    </span>",
"    &nbsp;&mdash;&nbsp;Review of the clinical features, management, and outcome of 407 cases of epiglottitis from a single state over an 18-year period suggests that the clinical features vary depending upon whether or not Hib is the causative pathogen [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hib epiglottis is associated with the \"classic\" features: it is more common in young children, is rapidly progressive, involves the epiglottis more than the surrounding structures, and has a high risk of airway obstruction.",
"     </li>",
"     <li>",
"      Non-Hib epiglottitis is more common in adults and generally has a slower onset, greater involvement of the supraglottal structures than the epiglottis, and a lower risk of airway obstruction.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Airway obstruction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Airway obstruction may occur unpredictably at any point in the illness or treatment course [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Epiglottic abscess",
"    </span>",
"    &nbsp;&mdash;&nbsp;Epiglottic abscess may result from coalescent epiglottic infection or secondary infection of an epiglottic mucocele [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/67,68\">",
"     67,68",
"    </a>",
"    ]. Epiglottic abscess occurs predominantly in adults and may complicate as many as 30 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/67\">",
"     67",
"    </a>",
"    ]. A 17-year-old patient with an abscess of the aryepiglottic fold presenting as epiglottitis has been described [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/69\">",
"     69",
"    </a>",
"    ]. Patients with epiglottic abscess have more severe symptoms and are at increased risk of airway compromise compared with those without this complication [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/50,60,67,70\">",
"     50,60,67,70",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Epiglottic abscess can be diagnosed by direct visualization or computed tomography (which should be performed only in patients with a stable airway). Treatment of epiglottic abscess requires drainage in addition to airway management and antibiotic therapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/16/12553?source=see_link\">",
"     \"Epiglottitis (supraglottitis): Treatment and prevention\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Secondary infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Secondary infection (eg, pneumonia, cervical adenitis, cellulitis, septic arthritis, and meningitis) may result as a consequence of bacteremia or direct extension. Meningitis occurs rarely [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/63,71\">",
"     63,71",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Necrotizing epiglottitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Necrotizing epiglottitis is a rare complication of epiglottitis in patients with immunodeficiency (eg, HIV infection, hemophagocytic lymphohistiocytosis) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/72-74\">",
"     72-74",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Death",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mortality rates in children and adults are &lt;1 and &le;3.3 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/13-16,30,49\">",
"     13-16,30,49",
"    </a>",
"    ]. Death is almost always due to acute airway obstruction. Most deaths occur en route to the hospital or soon after arrival.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diagnosis of epiglottitis is made by visualization of the epiglottis (",
"    <a class=\"graphic graphic_picture graphicRef74563 \" href=\"UTD.htm?28/19/28978\">",
"     picture 5",
"    </a>",
"    ) or demonstration of epiglottal swelling on lateral neck radiographs (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef67312 \" href=\"UTD.htm?41/42/42663\">",
"     image 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/3,75\">",
"     3,75",
"    </a>",
"    ]. Cultures of the blood",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    surface of the epiglottis identify the microbial pathogen. A rapid overview of the approach to diagnosis and treatment of epiglottitis in children is provided in the table (",
"    <a class=\"graphic graphic_table graphicRef80169 \" href=\"UTD.htm?25/10/25773\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Maintenance of the airway is the mainstay of treatment. In patients with signs of total or near-total airway obstruction, airway control necessarily precedes diagnostic evaluation [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/16/12553?source=see_link\">",
"     \"Epiglottitis (supraglottitis): Treatment and prevention\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/48/29450?source=see_link\">",
"     \"Emergent endotracheal intubation in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/14/36068?source=see_link\">",
"     \"Advanced emergency airway management in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Clinical suspicion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Epiglottitis should be suspected in young children who present with the characteristic clinical features: \"tripod\" position (",
"    <a class=\"graphic graphic_picture graphicRef79826 \" href=\"UTD.htm?25/54/26465\">",
"     picture 1",
"    </a>",
"    ), anxiety (",
"    <a class=\"graphic graphic_picture graphicRef76538 \" href=\"UTD.htm?8/0/8197\">",
"     picture 2",
"    </a>",
"    ), stridor, drooling, sore throat, dysphagia, and inspiratory distress. Because of the potential for rapid progression to complete airway obstruction, the threshold for suspicion of epiglottitis should be low.",
"   </p>",
"   <p>",
"    Epiglottitis should be suspected in older children, adolescents, and adults in whom the severity of sore throat is out of proportion to the findings on oropharyngeal examination [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Overview of approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;The approach to diagnosis is as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Impending obstruction or strong suspicion of epiglottitis",
"      </strong>",
"      &ndash; In the patient with impending or complete obstruction, or with a convincing picture of epiglottitis, proceed directly to airway management without attempting visualization. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/48/29450?source=see_link\">",
"       \"Emergent endotracheal intubation in children\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/14/36068?source=see_link\">",
"       \"Advanced emergency airway management in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Child with moderate to severe distress",
"      </strong>",
"      &ndash; In the child with moderate to severe distress, but without signs of impending obstruction, for whom the differential diagnosis is not limited to epiglottitis (",
"      <a class=\"graphic graphic_table graphicRef51465 \" href=\"UTD.htm?39/12/40140\">",
"       table 3",
"      </a>",
"      ), obtain a lateral neck radiograph in the presence of appropriately skilled personnel and monitoring without attempting visualization. (See",
"      <a class=\"local\" href=\"#H32\">",
"       'Radiographs'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      <strong>",
"       Child with mild to moderate distress",
"      </strong>",
"      &ndash; In the child with mild to moderate respiratory distress, attempt visualization of the epiglottis using a tongue depressor, but proceed to radiography if the procedure causes agitation or the epiglottis is not seen. (See",
"      <a class=\"local\" href=\"#H31\">",
"       'Visualization'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      <strong>",
"       Adult with mild to moderate distress",
"      </strong>",
"      &ndash; In the adult with mild to moderate respiratory distress, attempt visualization of the epiglottis using a tongue depressor, proceeding either to radiography or to flexible laryngoscopy if the epiglottis is not seen. (See",
"      <a class=\"local\" href=\"#H31\">",
"       'Visualization'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h3\">",
"     Visualization",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of epiglottitis is confirmed by visualization of an erythematous, edematous epiglottis (",
"    <a class=\"graphic graphic_picture graphicRef74563 \" href=\"UTD.htm?28/19/28978\">",
"     picture 5",
"    </a>",
"    ). The epiglottis may be inspected directly with the aid of a tongue depressor (in young children) or with direct or indirect laryngoscopy (eg, a mirror examination or flexible nasopharyngoscopy) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/30,76\">",
"     30,76",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Visualization of the epiglottis in a young child with suspected epiglottitis and signs of severe upper airway obstruction should be attempted only in a setting where the airway can be secured immediately if necessary (eg, the operating room, emergency department, or intensive care unit). (See",
"    <a class=\"local\" href=\"#H16\">",
"     'Examining children'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H17\">",
"     'Examination findings'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h3\">",
"     Radiographs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiographs are not necessary to make a diagnosis of epiglottitis, particularly if the patient shows signs of impending or complete airway obstruction, the clinical diagnosis is apparent, or the epiglottis is visualized using a tongue depressor, as tolerated, or flexible nasopharyngoscopy, if available. However, if radiographs can be obtained without placing the patient at risk (eg, by increasing anxiety in a child or requiring the patient to leave the emergency department), radiographic findings can confirm the diagnosis and be instrumental in mobilizing the multidisciplinary management team. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/16/12553?source=see_link\">",
"     \"Epiglottitis (supraglottitis): Treatment and prevention\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Findings on soft-tissue lateral neck radiographs that are consistent with epiglottitis include an enlarged epiglottis, loss of the vallecular air space, thickened aryepiglottic folds, a distended hypopharynx, and straightening of the cervical spine (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef67312 \" href=\"UTD.htm?41/42/42663\">",
"     image 1",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H20\">",
"     'Radiographic features'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Compared with visualization of the epiglottis, radiographs lack sensitivity (38 to 88 percent) and specificity (78 percent), and may delay diagnosis in critically ill patients [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/10,60,77\">",
"     10,60,77",
"    </a>",
"    ]. However, in patients with a subacute presentation, radiographs may be indicated to evaluate conditions in the differential diagnosis that are considered to be more likely than epiglottitis (",
"    <a class=\"graphic graphic_table graphicRef51465 \" href=\"UTD.htm?39/12/40140\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/64\">",
"     64",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H34\">",
"     'Differential diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3183320\">",
"    <span class=\"h2\">",
"     Ultrasound",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bedside ultrasound evaluation of the epiglottis in adults has been described but its role in diagnosing epiglottitis is unclear [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/78,79\">",
"     78,79",
"    </a>",
"    ]. The ultrasonographic appearance of epiglottitis in adults has been described as an &ldquo;alphabet P sign&rdquo;, formed by an acoustic shadow of the swollen epiglottis and hyoid bone at the level of the thyrohyoid membrane when imaged in longitudinal orientation [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/78\">",
"     78",
"    </a>",
"    ]. However, no pediatric experience with ultrasound has as yet been reported.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h2\">",
"     Microbiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;The etiologic diagnosis is made by culture of a pathogenic organism from the blood or the surface of the epiglottis.",
"   </p>",
"   <p>",
"    Blood and epiglottic cultures should be obtained after the airway is secure [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/5,60\">",
"     5,60",
"    </a>",
"    ]. Swabbing the epiglottis is difficult, potentially dangerous, and contraindicated in patients who are not intubated [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/34,80\">",
"     34,80",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Epiglottal cultures are positive in 33 to 75 percent of patients with epiglottitis [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/14,57,80,81\">",
"     14,57,80,81",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Blood cultures are positive in approximately 70 percent of children with epiglottitis [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/82\">",
"     82",
"    </a>",
"    ]. In adult case series, the yield of blood cultures ranges from 0 to 17 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of epiglottitis includes other causes of acute upper airway obstruction, including (",
"    <a class=\"graphic graphic_table graphicRef51465 \" href=\"UTD.htm?39/12/40140\">",
"     table 3",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Laryngotracheitis (croup) or spasmodic croup (angioedema-like response with less inflammation visible by laryngoscopy)",
"     </li>",
"     <li>",
"      Uvulitis",
"     </li>",
"     <li>",
"      Bacterial tracheitis",
"     </li>",
"     <li>",
"      Peritonsillar or retropharyngeal abscesses",
"     </li>",
"     <li>",
"      Foreign body lodged in the larynx or vallecula",
"     </li>",
"     <li>",
"      Angioedema (anaphylaxis or hereditary)",
"     </li>",
"     <li>",
"      Congenital anomalies of the upper airway",
"     </li>",
"     <li>",
"      Diphtheria",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The emergent evaluation of acute upper airway obstruction in children is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/61/10201?source=see_link\">",
"     \"Emergent evaluation of acute upper airway obstruction in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Croup",
"      </strong>",
"      &ndash; Epiglottitis is distinguished from croup by the absence of \"barking\" cough and the presence of anxiety and drooling. Children with croup generally are comfortable in the supine position and have a normal-appearing epiglottis, when visualized, on examination. Lateral neck radiographs in patients with croup may demonstrate distention of the hypopharynx during inspiration, subglottic haziness, and a normal epiglottis (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef64727 \" href=\"UTD.htm?41/59/42943\">",
"       image 3",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/32/43529?source=see_link&amp;anchor=H7#H7\">",
"       \"Clinical features, evaluation, and diagnosis of croup\", section on 'Clinical presentation'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Uvulitis",
"      </strong>",
"      &ndash; Infectious uvulitis may occur in conjunction with epiglottitis, pharyngitis, or as an isolated infection. In patients with isolated uvulitis with a massively swollen uvula, the presentation may mimic that of epiglottitis. Swelling and erythema of the uvula are the characteristic findings on examination (",
"      <a class=\"graphic graphic_picture graphicRef67939 \" href=\"UTD.htm?31/19/32049\">",
"       picture 6",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/25/10649?source=see_link&amp;anchor=H10#H10\">",
"       \"Clinical features and treatment of uvulitis\", section on 'Clinical features'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Bacterial tracheitis",
"      </strong>",
"      &ndash; Bacterial tracheitis may be a complication of viral laryngotracheitis (croup) or a primary bacterial infection. Primary bacterial tracheitis may present with acute onset of upper airway obstruction, fever, and toxic appearance, similar to epiglottitis. However, radiographs may demonstrate intraluminal membranes and irregularities of the tracheal wall, as well as a normal epiglottis and supraglottic region (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef80331 \" href=\"UTD.htm?33/50/34606\">",
"       image 4",
"      </a>",
"      ). Direct tracheoscopy may be necessary for diagnosis (",
"      <a class=\"graphic graphic_picture graphicRef55364 \" href=\"UTD.htm?16/55/17264\">",
"       picture 7",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/49/32536?source=see_link&amp;anchor=H11#H11\">",
"       \"Bacterial tracheitis in children: Clinical features and diagnosis\", section on 'Clinical features'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Peritonsillar or retropharyngeal infection",
"      </strong>",
"      &ndash; Children with peritonsillar or retropharyngeal",
"      <span class=\"nowrap\">",
"       cellulitis/abscess,",
"      </span>",
"      or other painful infections of the oropharynx, may present with drooling and neck extension [",
"      <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/83\">",
"       83",
"      </a>",
"      ]. Children with these infections usually are not as toxic appearing or anxious as those with acute epiglottitis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/61/31705?source=see_link\">",
"       \"Peritonsillar cellulitis and abscess\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/61/43992?source=see_link\">",
"       \"Retropharyngeal infections in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Foreign bodies",
"      </strong>",
"      &ndash; Foreign bodies in the larynx or trachea can cause complete or partial airway obstruction that requires immediate treatment. Foreign bodies lodged in the esophagus in the area of the cricoid cartilage or the tracheal bifurcation can compress the airway, causing partial airway obstruction. Symptoms are likely to have an abrupt onset, and fever is absent. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/61/10201?source=see_link&amp;anchor=H11#H11\">",
"       \"Emergent evaluation of acute upper airway obstruction in children\", section on 'Foreign bodies'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/22/1386?source=see_link\">",
"       \"Foreign bodies of the esophagus and gastrointestinal tract in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Angioedema (anaphylaxis or hereditary)",
"      </strong>",
"      &ndash; Allergic reaction or acute angioneurotic edema has rapid onset without antecedent cold symptoms or fever. The primary manifestations are swelling of the lips and tongue, urticarial rash, dysphagia without hoarseness, and sometimes inspiratory stridor [",
"      <a class=\"abstract\" href=\"UTD.htm?4/45/4826/abstract/84,85\">",
"       84,85",
"      </a>",
"      ]. There may be a history of allergy or a previous attack. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/29/35290?source=see_link\">",
"       \"Anaphylaxis: Rapid recognition and treatment\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Congenital anomalies",
"      </strong>",
"      &ndash; Congenital anomalies of the upper airway and laryngeal papillomas sometimes cause symptoms similar to those of epiglottitis. However, these conditions have a chronic course and generally do not cause fever (unless symptoms are due to exacerbation of airway narrowing due to a concomitant viral infection). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/42/37543?source=see_link\">",
"       \"Congenital anomalies of the larynx\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Diphtheria",
"      </strong>",
"      &ndash; The clinical presentation of diphtheria can be similar to that of epiglottitis. The onset of symptoms is typically gradual. Sore throat, malaise, and low-grade fever are the most common presenting symptoms. A diphtheritic membrane (gray and sharply demarcated, (",
"      <a class=\"graphic graphic_picture graphicRef51058 \" href=\"UTD.htm?2/20/2369\">",
"       picture 8",
"      </a>",
"      )) may be present. Diphtheria is exceedingly rare in countries with high rates of immunization for diphtheria, tetanus, and pertussis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/38/29287?source=see_link\">",
"       \"Epidemiology, pathophysiology and clinical manifestations of diphtheria\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/28/41417?source=see_link&amp;anchor=H7#H7\">",
"       \"Approach to diagnosis of acute infectious pharyngitis in children and adolescents\", section on 'Other bacteria'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Other causes of epiglottic enlargement",
"      </strong>",
"      &ndash; Other causes of epiglottic enlargement, such as neck radiation therapy or thermal injury, generally can be elucidated by history.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Epiglottitis (supraglottitis) is inflammation of the epiglottis and adjacent supraglottic structures. A rapid overview of the recognition and management of epiglottitis in children is provided in the table (",
"      <a class=\"graphic graphic_table graphicRef80169 \" href=\"UTD.htm?25/10/25773\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Definition'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Epiglottitis may be caused by a number of bacterial, viral, and fungal pathogens (",
"      <a class=\"graphic graphic_table graphicRef54481 \" href=\"UTD.htm?7/29/7644\">",
"       table 2",
"      </a>",
"      ). In the otherwise healthy child, most cases are bacterial. Epiglottitis also may be caused by trauma (eg, foreign body ingestion, thermal injury, caustic ingestion). (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Etiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Young children with epiglottitis classically present with respiratory distress, anxiety, and the characteristic \"sniffing\" posture (",
"      <a class=\"graphic graphic_picture graphicRef76538 \" href=\"UTD.htm?8/0/8197\">",
"       picture 2",
"      </a>",
"      ), but the presentation may be more subtle. Older children, adolescents, and adults may present with a severe sore throat, relatively mild respiratory symptoms, and anterior neck pain, but relatively normal oropharyngeal examination. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Diagnosis of epiglottitis is confirmed by visualization of the epiglottis. Visualization of the epiglottis should occur in a setting where the airway can be secured immediately if necessary. (See",
"      <a class=\"local\" href=\"#H28\">",
"       'Diagnosis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H16\">",
"       'Examining children'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Examination findings consistent with epiglottitis include inflammation and edema of the supraglottic structures (epiglottis, aryepiglottic folds, and arytenoid cartilages) (",
"      <a class=\"graphic graphic_picture graphicRef74563 \" href=\"UTD.htm?28/19/28978\">",
"       picture 5",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Examination findings'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Soft-tissue radiographs of the lateral neck are not necessary to make a diagnosis of epiglottitis, but may be indicated when other diagnostic considerations remain in the differential diagnosis (",
"      <a class=\"graphic graphic_table graphicRef51465 \" href=\"UTD.htm?39/12/40140\">",
"       table 3",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Radiographic features'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H34\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Radiographic findings consistent with epiglottitis include an enlarged epiglottis, loss of the vallecular air space, thickened aryepiglottic folds, a distended hypopharynx, and straightening of the cervical spine (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef67312 \" href=\"UTD.htm?41/42/42663\">",
"       image 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Radiographic features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Complications of epiglottitis include airway obstruction, epiglottic abscess, secondary infection, necrotizing epiglottitis (in immunocompromised patients), and death. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Complications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The differential diagnosis of epiglottitis includes other causes of acute upper airway obstruction (",
"      <a class=\"graphic graphic_table graphicRef51465 \" href=\"UTD.htm?39/12/40140\">",
"       table 3",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H34\">",
"       'Differential diagnosis'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/61/10201?source=see_link\">",
"       \"Emergent evaluation of acute upper airway obstruction in children\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/1\">",
"      Rafei K, Lichenstein R. Airway infectious disease emergencies. Pediatr Clin North Am 2006; 53:215.",
"     </a>",
"    </li>",
"    <li>",
"     Cherry JD. Epiglottitis (supraglottitis). In: Textbook of Pediatric Infectious Diseases, 6th, Feigin RD, Cherry JD, Demmler-Harrison GJ, Kaplan SL.  (Eds), Saunders, Philadelphia 2009. p.244.",
"    </li>",
"    <li>",
"     Fleisher GR. Infectious disease emergencies. In: Textbook of Pediatric Emergency Medicine, 5th, Fleisher GR, Ludwig S, Henretig FM.  (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2006. p.783.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/4\">",
"      Glynn F, Fenton JE. Diagnosis and management of supraglottitis (epiglottitis). Curr Infect Dis Rep 2008; 10:200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/5\">",
"      Stroud RH, Friedman NR. An update on inflammatory disorders of the pediatric airway: epiglottitis, croup, and tracheitis. Am J Otolaryngol 2001; 22:268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/6\">",
"      Shah RK, Roberson DW, Jones DT. Epiglottitis in the Hemophilus influenzae type B vaccine era: changing trends. Laryngoscope 2004; 114:557.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/7\">",
"      Tanner K, Fitzsimmons G, Carrol ED, et al. Haemophilus influenzae type b epiglottitis as a cause of acute upper airways obstruction in children. BMJ 2002; 325:1099.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/8\">",
"      Devlin B, Golchin K, Adair R. Paediatric airway emergencies in Northern Ireland, 1990-2003. J Laryngol Otol 2007; 121:659.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/9\">",
"      Gonz&aacute;lez Valdepe&ntilde;a H, Wald ER, Rose E, et al. Epiglottitis and Haemophilus influenzae immunization: the Pittsburgh experience--a five-year review. Pediatrics 1995; 96:424.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/10\">",
"      Solomon P, Weisbrod M, Irish JC, Gullane PJ. Adult epiglottitis: the Toronto Hospital experience. J Otolaryngol 1998; 27:332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/11\">",
"      Somenek M, Le M, Walner DL. Membranous laryngitis in a child. Int J Pediatr Otorhinolaryngol 2010; 74:704.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/12\">",
"      Sivakumar S, Latifi SQ. Varicella with stridor: think group A streptococcal epiglottitis. J Paediatr Child Health 2008; 44:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/13\">",
"      Mayo-Smith MF, Spinale JW, Donskey CJ, et al. Acute epiglottitis. An 18-year experience in Rhode Island. Chest 1995; 108:1640.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/14\">",
"      Frantz TD, Rasgon BM, Quesenberry CP Jr. Acute epiglottitis in adults. Analysis of 129 cases. JAMA 1994; 272:1358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/15\">",
"      Kucera CM, Silverstein MD, Jacobson RM, et al. Epiglottitis in adults and children in Olmsted County, Minnesota, 1976 through 1990. Mayo Clin Proc 1996; 71:1155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/16\">",
"      Torkkeli T, Ruoppi P, Nuutinen J, Kari A. Changed clinical course and current treatment of acute epiglottitis in adults a 12-year experience. Laryngoscope 1994; 104:1503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/17\">",
"      Lacroix J, Gauthier M, Lapointe N, et al. Pseudomonas aeruginosa supraglottitis in a six-month-old child with severe combined immunodeficiency syndrome. Pediatr Infect Dis J 1988; 7:739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/18\">",
"      Walsh TJ, Gray WC. Candida epiglottitis in immunocompromised patients. Chest 1987; 91:482.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/19\">",
"      Myer CM 3rd. Candida epiglottitis: clinical implications. Am J Otolaryngol 1997; 18:428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/20\">",
"      Harjacek M, Kornberg AE, Yates EW, Montgomery P. Thermal epiglottitis after swallowing hot tea. Pediatr Emerg Care 1992; 8:342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/21\">",
"      Kulick RM, Selbst SM, Baker MD, Woodward GA. Thermal epiglottitis after swallowing hot beverages. Pediatrics 1988; 81:441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/22\">",
"      Lai SH, Wong KS, Liao SL, Chou YH. Non-infectious epiglottitis in children: two cases report. Int J Pediatr Otorhinolaryngol 2000; 55:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/23\">",
"      Kavanagh KR, Batti JS. Traumatic epiglottitis after foreign body ingestion. Int J Pediatr Otorhinolaryngol 2008; 72:901.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/24\">",
"      Mayo-Smith MF, Spinale J. Thermal epiglottitis in adults: a new complication of illicit drug use. J Emerg Med 1997; 15:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/25\">",
"      Rosbe KW, Perez-Atayde AR, Roberson DW, Kenna M. Pathology forum: quiz case 1. Diagnosis: posttransplant lymphoproliferative disease (PTLD) of the epiglottis. Arch Otolaryngol Head Neck Surg 2000; 126:1153; discussion 1157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/26\">",
"      de Diego JI, Prim MP, Hardisson D, et al. Graft-vs-host disease as a cause of enlargement of the epiglottis in an immunocompromised child. Arch Otolaryngol Head Neck Surg 2001; 127:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/27\">",
"      Centers for Disease Control and Prevention (CDC). Progress toward elimination of Haemophilus influenzae type b invasive disease among infants and children--United States, 1998-2000. MMWR Morb Mortal Wkly Rep 2002; 51:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/28\">",
"      Garpenholt O, Hugosson S, Fredlund H, et al. Epiglottitis in Sweden before and after introduction of vaccination against Haemophilus influenzae type b. Pediatr Infect Dis J 1999; 18:490.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/29\">",
"      Garner D, Weston V. Effectiveness of vaccination for Haemophilus influenzae type b. Lancet 2003; 361:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/30\">",
"      Guldfred LA, Lyhne D, Becker BC. Acute epiglottitis: epidemiology, clinical presentation, management and outcome. J Laryngol Otol 2008; 122:818.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/31\">",
"      McVernon J, Slack MP, Ramsay ME. Changes in the epidemiology of epiglottitis following introduction of Haemophilus influenzae type b (Hib) conjugate vaccines in England: a comparison of two data sources. Epidemiol Infect 2006; 134:570.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/32\">",
"      Senior BA, Radkowski D, MacArthur C, et al. Changing patterns in pediatric supraglottitis: a multi-institutional review, 1980 to 1992. Laryngoscope 1994; 104:1314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/33\">",
"      Wood N, Menzies R, McIntyre P. Epiglottitis in Sydney before and after the introduction of vaccination against Haemophilus influenzae type b disease. Intern Med J 2005; 35:530.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/34\">",
"      Nakamura H, Tanaka H, Matsuda A, et al. Acute epiglottitis: a review of 80 patients. J Laryngol Otol 2001; 115:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/35\">",
"      Gorelick MH, Baker MD. Epiglottitis in children, 1979 through 1992. Effects of Haemophilus influenzae type b immunization. Arch Pediatr Adolesc Med 1994; 148:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/36\">",
"      Briem B, Thorvardsson O, Petersen H. Acute epiglottitis in Iceland 1983-2005. Auris Nasus Larynx 2009; 36:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/37\">",
"      Faden H. The dramatic change in the epidemiology of pediatric epiglottitis. Pediatr Emerg Care 2006; 22:443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/38\">",
"      Shah RK, Nussenbaum B, Kienstra M, et al. Wrong-site sinus surgery in otolaryngology. Otolaryngol Head Neck Surg 2010; 143:37.",
"     </a>",
"    </li>",
"    <li>",
"     Annual Estimates of the Population by Five-Year Age Groups and Sex for the United States: April 1, 2000 to July 1, 2006 (NC-EST2006-01). file://www.census.gov/popest/national/asrh/NC-EST2006-sa.html (Accessed on April 22, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/40\">",
"      Lee AC, Lam SY. Life threatening acute epiglottitis in acute leukemia. Leuk Lymphoma 2002; 43:665.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/41\">",
"      Cocks HC, Johnson IJ. Acute epiglottitis: a presentation of haemophagocytic lymphohistiocytosis. J Laryngol Otol 2001; 115:819.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/42\">",
"      Murray JC, Chiu JK, Dorfman SR, Ogden AK. Epiglottitis following preparation for allogeneic bone marrow transplantation. Bone Marrow Transplant 1995; 15:997.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/43\">",
"      Charuvanij S, Houghton KM. Acute epiglottitis as the initial presentation of pediatric Systemic Lupus Erythematosus. Pediatr Rheumatol Online J 2009; 7:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/44\">",
"      Ambrosino DM, Schiffman G, Gotschlich EC, et al. Correlation between G2m(n) immunoglobulin allotype and human antibody response and susceptibility to polysaccharide encapsulated bacteria. J Clin Invest 1985; 75:1935.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/45\">",
"      Granoff DM, Pandey JP, Boies E, et al. Response to immunization with Haemophilus influenzae type b polysaccharide-pertussis vaccine and risk of Haemophilus meningitis in children with the Km(1) immunoglobulin allotype. J Clin Invest 1984; 74:1708.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/46\">",
"      Tejani A, Mahadevan R, Dobias B, et al. Occurrence of HLA types in H. influenzae type B disease. Tissue Antigens 1981; 17:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/47\">",
"      Whisnant JK, Rogentine GN, Gralnick MA, et al. Host factors and antibody response Haemophilus influenza type b meningitis and epiglottitis. J Infect Dis 1976; 133:448.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/48\">",
"      Ng HL, Sin LM, Li MF, et al. Acute epiglottitis in adults: a retrospective review of 106 patients in Hong Kong. Emerg Med J 2008; 25:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/49\">",
"      Chang YL, Lo SH, Wang PC, Shu YH. Adult acute epiglottitis: experiences in a Taiwanese setting. Otolaryngol Head Neck Surg 2005; 132:689.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/50\">",
"      Wolf M, Strauss B, Kronenberg J, Leventon G. Conservative management of adult epiglottitis. Laryngoscope 1990; 100:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/51\">",
"      Park KW, Darvish A, Lowenstein E. Airway management for adult patients with acute epiglottitis: a 12-year experience at an academic medical center (1984-1995). Anesthesiology 1998; 88:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/52\">",
"      BERENBERG W, KEVY S. Acute epiglottitis in childhood; a serious emergency, readily recognized at the bedside. N Engl J Med 1958; 258:870.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/53\">",
"      Losek JD, Dewitz-Zink BA, Melzer-Lange M, Havens PL. Epiglottitis: comparison of signs and symptoms in children less than 2 years old and older. Ann Emerg Med 1990; 19:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/54\">",
"      RABE EF. Infectious croup; Hemophilus influenzae type B croup. Pediatrics 1948; 2:559.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/55\">",
"      Johnson GK, Sullivan JL, Bishop LA. Acute epiglottitis. Review of 55 cases and suggested protocol. Arch Otolaryngol 1974; 100:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/56\">",
"      Battaglia JD, Lockhart CH. Management of acute epiglottitis by nasotracheal intubation. Am J Dis Child 1975; 129:334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/57\">",
"      H&eacute;bert PC, Ducic Y, Boisvert D, Lamothe A. Adult epiglottitis in a Canadian setting. Laryngoscope 1998; 108:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/58\">",
"      Tibballs J, Watson T. Symptoms and signs differentiating croup and epiglottitis. J Paediatr Child Health 2011; 47:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/59\">",
"      Madhotra D, Fenton JE, Makura ZG, et al. Airway intervention in adult supraglottitis. Ir J Med Sci 2004; 173:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/60\">",
"      Sobol SE, Zapata S. Epiglottitis and croup. Otolaryngol Clin North Am 2008; 41:551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/61\">",
"      Carey MJ. Epiglottitis in adults. Am J Emerg Med 1996; 14:421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/62\">",
"      Ehara H. Tenderness over the hyoid bone can indicate epiglottitis in adults. J Am Board Fam Med 2006; 19:517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/63\">",
"      Molteni RA. Epiglottitis: incidence of extraepiglottic infection: report of 72 cases and review of the literature. Pediatrics 1976; 58:526.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/64\">",
"      Ragosta KG, Orr R, Detweiler MJ. Revisiting epiglottitis: a protocol--the value of lateral neck radiographs. J Am Osteopath Assoc 1997; 97:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/65\">",
"      Ducic Y, H&eacute;bert PC, MacLachlan L, et al. Description and evaluation of the vallecula sign: a new radiologic sign in the diagnosis of adult epiglottitis. Ann Emerg Med 1997; 30:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/66\">",
"      Schumaker HM, Doris PE, Birnbaum G. Radiographic parameters in adult epiglottitis. Ann Emerg Med 1984; 13:588.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/67\">",
"      Berger G, Landau T, Berger S, et al. The rising incidence of adult acute epiglottitis and epiglottic abscess. Am J Otolaryngol 2003; 24:374.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/68\">",
"      Stack BC Jr, Ridley MB. Epiglottic abscess. Head Neck 1995; 17:263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/69\">",
"      Reed J, Shah RK, Jantausch B, Choi SS. Aryepiglottic abscess manifesting as epiglottitis. Arch Otolaryngol Head Neck Surg 2009; 135:953.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/70\">",
"      Cable BB, Biega T. Radiology forum. Quiz case 1. Adult epiglottitis with epiglottic abscess. Arch Otolaryngol Head Neck Surg 2001; 127:212, 214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/71\">",
"      Schuh S, Huang A, Fallis JC. Atypical epiglottitis. Ann Emerg Med 1988; 17:168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/72\">",
"      Tebruegge M, Connell T, Kong K, et al. Necrotizing epiglottitis in an infant: an unusual first presentation of human immunodeficiency virus infection. Pediatr Infect Dis J 2009; 28:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/73\">",
"      Kong MS, Engel SH, Zalzal GH, Preciado D. Necrotizing epiglottitis and hemophagocytic lymphohistiocytosis. Int J Pediatr Otorhinolaryngol 2009; 73:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/74\">",
"      Seng&ouml;r A, Willke A, Aydin O, et al. Isolated necrotizing epiglottitis: report of a case in a neutropenic patient and review of the literature. Ann Otol Rhinol Laryngol 2004; 113:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/75\">",
"      Andreassen UK, Baer S, Nielsen TG, et al. Acute epiglottitis--25 years experience with nasotracheal intubation, current management policy and future trends. J Laryngol Otol 1992; 106:1072.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/76\">",
"      Damm M, Eckel HE, Jungeh&uuml;lsing M, Roth B. Airway endoscopy in the interdisciplinary management of acute epiglottitis. Int J Pediatr Otorhinolaryngol 1996; 38:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/77\">",
"      Stankiewicz JA, Bowes AK. Croup and epiglottitis: a radiologic study. Laryngoscope 1985; 95:1159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/78\">",
"      Hung TY, Li S, Chen PS, et al. Bedside ultrasonography as a safe and effective tool to diagnose acute epiglottitis. Am J Emerg Med 2011; 29:359.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/79\">",
"      Werner SL, Jones RA, Emerman CL. Sonographic assessment of the epiglottis. Acad Emerg Med 2004; 11:1358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/80\">",
"      Hafidh MA, Sheahan P, Keogh I, Walsh RM. Acute epiglottitis in adults: a recent experience with 10 cases. J Laryngol Otol 2006; 120:310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/81\">",
"      Chan KO, Pang YT, Tan KK. Acute epiglottitis in the tropics: is it an adult disease? J Laryngol Otol 2001; 115:715.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/82\">",
"      McEwan J, Giridharan W, Clarke RW, Shears P. Paediatric acute epiglottitis: not a disappearing entity. Int J Pediatr Otorhinolaryngol 2003; 67:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/83\">",
"      Lee SS, Schwartz RH, Bahadori RS. Retropharyngeal abscess: epiglottitis of the new millennium. J Pediatr 2001; 138:435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/84\">",
"      Cherry JD. Clinical practice. Croup. N Engl J Med 2008; 358:384.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/45/4826/abstract/85\">",
"      Bjornson CL, Johnson DW. Croup. Lancet 2008; 371:329.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6080 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-197.136.42.3-1F0470BBCD-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_45_4826=[""].join("\n");
var outline_f4_45_4826=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H35\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ANATOMY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Infectious causes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Noninfectious causes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Incidence and median age",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Risk factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Presentation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Children",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Adults",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Examination",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Examining children",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Examination findings",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Extra-epiglottic foci",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Laboratory features",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Radiographic features",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Hib versus non-Hib",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Airway obstruction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Epiglottic abscess",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Secondary infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Necrotizing epiglottitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Death",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Clinical suspicion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Overview of approach",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      - Visualization",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      - Radiographs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3183320\">",
"      Ultrasound",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      Microbiology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/6080\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6080|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?41/42/42663\" title=\"diagnostic image 1\">",
"      Epiglottitis radiograph",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?22/26/22958\" title=\"diagnostic image 2\">",
"      Epiglottitis x-ray",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?41/59/42943\" title=\"diagnostic image 3\">",
"      Croup lateral neck",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?33/50/34606\" title=\"diagnostic image 4\">",
"      Bacterial tracheitis x-ray",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6080|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?1/54/1894\" title=\"figure 1\">",
"      Supraglottic anatomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6080|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?25/54/26465\" title=\"picture 1\">",
"      Epiglottitis tripod posture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?8/0/8197\" title=\"picture 2\">",
"      Epiglottitis classic",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?1/45/1747\" title=\"picture 3\">",
"      Epiglottitis subtle",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?5/51/5937\" title=\"picture 4\">",
"      Epiglottitis visualization",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?28/19/28978\" title=\"picture 5\">",
"      Acute epiglottitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?31/19/32049\" title=\"picture 6\">",
"      Uvulitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?16/55/17264\" title=\"picture 7\">",
"      Bacterial tracheitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?2/20/2369\" title=\"picture 8\">",
"      Diphtheritic membrane",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6080|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?25/10/25773\" title=\"table 1\">",
"      Epiglottitis in children &ndash; Rapid overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?7/29/7644\" title=\"table 2\">",
"      Epiglottitis microbiology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?39/12/40140\" title=\"table 3\">",
"      Causes of pediatric acute airway obstruction",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/14/36068?source=related_link\">",
"      Advanced emergency airway management in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/29/35290?source=related_link\">",
"      Anaphylaxis: Rapid recognition and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/28/41417?source=related_link\">",
"      Approach to diagnosis of acute infectious pharyngitis in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/49/32536?source=related_link\">",
"      Bacterial tracheitis in children: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/25/10649?source=related_link\">",
"      Clinical features and treatment of uvulitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/32/43529?source=related_link\">",
"      Clinical features, evaluation, and diagnosis of croup",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/42/37543?source=related_link\">",
"      Congenital anomalies of the larynx",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/48/29450?source=related_link\">",
"      Emergent endotracheal intubation in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/61/10201?source=related_link\">",
"      Emergent evaluation of acute upper airway obstruction in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/38/29287?source=related_link\">",
"      Epidemiology, pathophysiology and clinical manifestations of diphtheria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/16/12553?source=related_link\">",
"      Epiglottitis (supraglottitis): Treatment and prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/22/1386?source=related_link\">",
"      Foreign bodies of the esophagus and gastrointestinal tract in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/61/31705?source=related_link\">",
"      Peritonsillar cellulitis and abscess",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/61/43992?source=related_link\">",
"      Retropharyngeal infections in children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f4_45_4827="Mech supple oxy may red dys";
var content_f4_45_4827=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F54116&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F54116&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Mechanisms by which supplemental oxygen may reduce dyspnea",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Reversal of hypoxemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Reduced serum lactic acid",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Reduced pulmonary artery pressure",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Reduced dynamic hyperinflation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Reduced ventilatory muscle and diaphragm fatigue",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Relief of bronchoconstriction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stimulation of facial, nasal or pharyngeal receptors",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Increased capacity for exercise training",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Placebo effect",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_45_4827=[""].join("\n");
var outline_f4_45_4827=null;
var title_f4_45_4828="Modified CCI";
var content_f4_45_4828=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F65323&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F65323&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Modified Charlson comorbidity index",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Comorbid condition",
"       </td>",
"       <td class=\"subtitle1\">",
"        Point",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Myocardial infarction",
"       </td>",
"       <td>",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Heart failure",
"       </td>",
"       <td>",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cerebrovascular disease",
"       </td>",
"       <td>",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ulcer",
"       </td>",
"       <td>",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hepatic disease (mild)",
"       </td>",
"       <td>",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Diabetes (mild or moderate)",
"       </td>",
"       <td>",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pulmonary disease (moderate or severe)",
"       </td>",
"       <td>",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Connective tissue disease",
"       </td>",
"       <td>",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Diabetes (severe with end-organ damage)",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Renal disease (moderate or severe)",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Solid tumor (without metastases)",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hepatic disease (moderate or severe)",
"       </td>",
"       <td>",
"        3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Solid tumor (with metastases)",
"       </td>",
"       <td>",
"        6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Total score",
"        </strong>",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Etienne, A, Esterni, B, Charbonnier, A, et al. Comorbidity is an independent predictor of complete remission in elderly patients receiving induction chemotherapy for acute myeloid leukemia. Cancer 2007; 109:1376. Copyright &copy; 2007 American Cancer Society. This material is reproduced with permission of Wiley-Liss, Inc., a subsidiary of John Wiley &amp; Sons, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_45_4828=[""].join("\n");
var outline_f4_45_4828=null;
var title_f4_45_4829="Minor heat illness treatment in children";
var content_f4_45_4829=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F70997&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F70997&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Evaluation and management of minor heat illness in children",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Condition",
"      </td>",
"      <td class=\"subtitle1\">",
"       Core body temperature",
"      </td>",
"      <td class=\"subtitle1\">",
"       Clinical findings",
"      </td>",
"      <td class=\"subtitle1\">",
"       Treatment",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Miliaria (heat rash)",
"      </td>",
"      <td>",
"       Normal",
"      </td>",
"      <td>",
"       Pruritic erythematus or skin colored papular, vesicular, or pustular rash",
"      </td>",
"      <td>",
"       <p>",
"        Light clothing to decrease sweating",
"       </p>",
"       <p>",
"        Symptomatic treatment of pruritus",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Heat edema",
"      </td>",
"      <td>",
"       Normal",
"      </td>",
"      <td>",
"       Swelling of feet, ankles, and/or lower legs",
"      </td>",
"      <td>",
"       <p>",
"        Cool environment*",
"       </p>",
"       <p>",
"        Elevation of legs",
"       </p>",
"       <p>",
"        Compression stockings",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Heat syncope",
"      </td>",
"      <td>",
"       Normal",
"      </td>",
"      <td>",
"       Dizziness, orthostatic hypotension, and syncope after exertion with rapid return to normal mental status when supine",
"      </td>",
"      <td>",
"       <p>",
"        Move to cool environment*",
"       </p>",
"       <p>",
"        Supine position",
"       </p>",
"       <p>",
"        Oral rehydration with salt-containing fluids&bull; or intravenous normal saline (initial infusion 20 mL per kg)",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Heat cramps",
"      </td>",
"      <td>",
"       Normal or elevated up to 40&deg;C (104&deg;F)",
"      </td>",
"      <td>",
"       Painful cramps of large muscle groups in the legs (eg, quadriceps, gastrocnemius) occurring after exertion",
"      </td>",
"      <td>",
"       <p>",
"        Passively stretch affected muscle",
"       </p>",
"       <p>",
"        Oral rehydration with salt-containing fluids&bull; or intravenous normal saline (initial infusion 20 mL per kg, maximum initial volume: 1 L)",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Heat tetany",
"      </td>",
"      <td>",
"       Normal or elevated up to 40&deg;C (104&deg;F)",
"      </td>",
"      <td>",
"       Hyperventilation with carpopedal spasm, paresthesias",
"      </td>",
"      <td>",
"       <p>",
"        Move to cool environment*",
"       </p>",
"       <p>",
"        If symptoms persistent, low flow (&lt;5 L per min.) oxygen via a partial rebreathing mask to encourage rebreathing of CO2",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"3\">",
"       Heat exhaustion",
"      </td>",
"      <td rowspan=\"3\">",
"       Elevated up to 40&deg;C (104&deg;F)",
"      </td>",
"      <td rowspan=\"3\">",
"       <p>",
"        Normal mental status, dizziness, brief episode of syncope, or mild confusion that rapidly normalizes within 30 minutes of treatment",
"       </p>",
"       <p>",
"        Tachycardia with normal blood pressure and mild to moderate dehydration",
"       </p>",
"       <p>",
"        Nausea, vomiting, headache, fatigue, weakness, thirst, sweating, or, in some patients, hyponatremia or hypernatremia",
"       </p>",
"      </td>",
"      <td>",
"       <p>",
"        Cease exertion immediately",
"       </p>",
"       <p>",
"        Move to cool environment*",
"       </p>",
"       <p>",
"        Remove excess clothing",
"       </p>",
"       <p>",
"        Oral rehydration with cool, salt-containing liquids&bull;",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1_start\">",
"       If symptoms continue despite above measures or if altered mental status:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       <p>",
"        - Measure rectal temperature",
"       </p>",
"       <p>",
"        - Measure serum electrolytes",
"       </p>",
"       <p>",
"        - Administer IV normal saline (initial infusion 20 mL per kg, maximum initial volume: 1 L)",
"       </p>",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Cool environments include natural shade, an air conditioned vehicle, or air conditioned building.",
"     <br>",
"      &bull; Flavored sports drinks (eg, Gatorade&reg;) may be used.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Data from:",
"     <br>",
"      1. Howe, AS, Boden, BP. Heat-related illness in athletes. Am J Sports Med 2007; 35:1384.",
"      <br>",
"       2. DeFranco, MJ, Baker CL, 3rd, DaSilva, JJ, et al. Environmental issues for team physicians. Am J Sports Med 2008; 36:2226.",
"      </br>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_45_4829=[""].join("\n");
var outline_f4_45_4829=null;
var title_f4_45_4830="Oxygen flow rate and FiO2";
var content_f4_45_4830=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F60292&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F60292&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 481px\">",
"   <div class=\"ttl\">",
"    Oxygen delivery via nasal cannula and FiO2",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 461px; height: 279px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Relation between oxygen flow rate via nasal cannula and the fraction of inspired oxygen (FiO2). Each additional L/min in oxygen flow increases the FiO2 by about 4 percent (shown as a separate block on each sequential column).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_45_4830=[""].join("\n");
var outline_f4_45_4830=null;
var title_f4_45_4831="Procoagulants outcome MI";
var content_f4_45_4831=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F61441&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F61441&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Elevated procoagulant levels after thrombolysis predict outcome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 320px; height: 513px; background-image: url(data:image/gif;base64,R0lGODlhQAEBAuYAAP///4CAgAAAAEBAQMDAwP+AgICZ/wBmM4CzmQAz/xAQELCwsKCgoCAgIDAwMFBQUHBwcODg4NDQ0PDw8ECMZpCQkMDZzaDGs2BgYP8AAEBm/8DN/xBwQPD286Cz/xBA//+goLDA/1Bz//Dz/7DQwDCDWSB5Tf/w8FCWc9Dj2f9AQP/AwDBZ/yBN/2CggP9QUHCpjeDs5tDZ/2CA/+Dm/3CN/5C8ppCm//9gYP8QEP8gIP8wMP/Q0P+wsP/g4P9wcP+QkEBNgL9AQL+AgHCWgzBWQ29Mv88JL38Zf4CMvz8mv0BZvyA/v59Tn78cUN+20AAZf58TX++Dj6+Pz6C2o+8DD3BzgN+tpr9NgJ+T379cj88TCSAyf+9zgCA871Azv59GMq+Av0BfUN92j2AwrxAmgGBQMO9DUAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAABAAQECAAf/gACCg4SFhoeIiYqLjI2Oj5CRkpOUlZaXmJmam5ydnp+goaKjpKWmp6ipqqusra6vsLGys7S1tre4ubq7vL2+v8DBwsPExcbHyMnKy8zNzs/Q0dLT1NXW19jZ2tvc3d7f4OHi4+Tl5ufo6err7O3u7/Dx8vP09fbEBBKHERUBC4P8/N0buEtCAAEDDEVQoMCBAAgAFjZ8SLCirQECEBqCIKACAAUCJnD0CHKCxZOyCGgshJEAgJYtXwogQCCAzZs4c+rcybOnz59AgwodSrSo0aNIXVJTmZDlTJkEYrasaTMIFC5WkGrdyrWr169ghQ4IUI2poQcC/jmUgFatAH2D/5IsEZFAxA0ZKJXZpCahggAHBExqZCDgwQIBDQAQNoy40N4RHkR8+CDCw4i8xfZOw5jx6UoIIB3ABf0X7iDNg2TcYPFhBl7MwVC3k01IxowPLCzD9kV7XW9CkFm73r3rdzrjhWzj9kAcF/JzzwtBbtGCeXNa0ctlN+SBeojrsraPE2/oRgLr4F2RD7e+kIfz6dWTfdfePfz4q+q/YsBgwgMMquhHyHvo4XeKgK00UAEGGXmECoKDhNCCBjQYeOB8v8zkwAAQNDUKVQEMUMQFmIxgQAIGXGbhKBCuosBBNnkoCogiHmBDJjRo0MJ3K4bSoiocaQjggwGQYIIJF3SACf+BPYLyYyoTVLDABAGYZopmF6BwAAokXMJkk508iQoEDAjSTyqydXABBzB4eR+YmohZygQEOIABTQ/IWEpvMZRQQgyWfAknJnKSolJnGQ15ISIwcNBlJe/xOKglhY4SQQANjBVABSahMoQQICBywQEkQvqBipNSUikpEkTQyqc66FDArCCcMMiopVIiggipVrLqKGwNICxERAIAwqwFvJDBCwX0sAIVpFYywgeS9grJr6I0gKiepPR2Agg/qLBDBhlsocIPza5g6yMhnGptJNiGUlgkEzAQQH8K9WNlQGUSkt0JV5gBRrjjZrDDuemue8iu716LoS8PEPuIQxg5UIj/BAxp+49iAigwwAOOPaxICia4MMgJK/RQAMHkHvwDECsMMm21DSsSLygYeDwsI4eB3BYhbUXQmNANdBryIx34qSQiKKuMw7g74ABEGC2gWnMiN3/CWUbcGgIjAF8PgtE/GQHglwMgeUSjyIy4YEIKj6wAxNMG4wCCD1cjkjUsX4ctCGEel30QBguAFMHaktjAgQWSbKDEGMruUAAPefvLdkEOEaAgI35BNFIhC9yrkV9kxXTa5YysCXckM8wgSA84xIpDD5Xv3QnaChDQISNEay6AqxpFsMACDv1DdOEKGA026ozYYMLSj9DwwQaE8FDAuC/U2rDtnKQ1QE1dG8KA/7YN9KvRoQ5srBj5Vi5fiQslSGKABof4AIIKGcxuLfebKFDBAAtogKKuxLxGlMBkkBhBdRLhAyDoIAc/oNyg+BcnRCllUZXogAluBIl2vSYRPPhBDnQABLw1iYKa+J9hAlTARqSAA7lyhAFYYLVEwC4DKtCehVB4jB+RIFqQYJgjvqWs7CkMPDysxAAk0CFhcQhNLXQErhLIAgNEgojL0mFzkkiJmWxtJRjExBQfIQNqTQKLRiQOF4khpzE6woOVQKMWT7JGSoxFEBAAWbE24cZGzLCGkpDjEQdSx0hcKlM22RAUO9FHRggRE4IkSCEhcShERTETiGPkAR7ViBFUkf8TkazHJB9BJzvRpH2hyCQjObC6RpSxQJoIZTxG+QtswaAE0GPEBj5QA1DIcjaXpAUDQMK1RYKCAgh0BA1YwIIK+RIERZzjcYI5iwZoawAKGOCeqCmJDnCAg4+ogRlF8ctwfGtWK6DlI9IiAABAQJvd4qYkUnCAVr6Rl6VAYwm/gUZ0qtMRGgpAnowZCsXlshHLbKYpiDjC2Z1ABhswgEQnStGKWvSiGJXoBj64il/+sxF2OghF9igKF1BgEuKE5SZoEFGLGgEJR8jAEZBghIza9KYWrYGOEjChGhggBBtwJih4sIJkZXGQgvjoIyrgIJKGImltkoSEFogJ1cxAAwn/SIAGZnDRjZ4Adg98ARAkKAqISlQDGvhAAj6AVol6YAPUkwQPgBAuHWRAB+eS5tGCEboKuIqgonhhDCHRHapGQjWSoYwBggqJBsYOh81CaihYGoKz7pSnbf0pY6sHhBfkIAfMWgFZG6HURQSpY6hkkTwrQQJWQoo6ixUqdyaaWLtwNI4qw58OcJAuE6YCrh6wrBeUQAYsnCEHVXCCFp7gq9W+ojAEKJwew0gK1QXqqlndakVhK9G7iGKuBVCBCnKQgRyIF52+/UTTViaulp1LClOYX1rXmlmgAtJrznUFYJIavkLU617KE0RATGOQe+EXFTB4Ho5aSlGVpsIHKSsA/w7wh0PeIuvCGM6whtlbMJclbBGUNYBOWZBVFmigBrrZ6y86FKOx9CsRFPvLxTKWFkEgSmJJze/7cHkNCG/4x0CelbMkS4kRbKCydBEBRTdQWkV8sZiJ6BkAfjaIoDVGMQCQQNkspwoKnPRqkFlykxMhAZqYOR82EwBZ/CYTsrUTIFc+nSqSlszK5XgafVMzIQDHGaDVWJWo0GBU7ew+aXTOnR0BneiaMgGM9AvQqBAsoQsdjd5pC3gJER7xahwBitnkr3dmhaTtPGZDLLFVkRgfYsyXEPRtrJIZuSClV9FaBJBax6rwHq4vUcgUlAAFB93frlGhLUSBkYCw6AAKSv9gT2H/gi0KyNTOnOoKBDiqZqU+BANkDdhXNHJS2T6ECtVHXVh8G07hLsRpa0xtcwMxVekmhJ79018nDdsT5+5RvAfB7t21Oxb53uG9UYGWATikqci+Ra3BPfBT+KdjOE74LXwNbHQ3PBqQroWymQ2mfbci47aw9mDx43G+XTwURqIA4wQOj3h3wNouABTJT06KKN3kxRLvRQxcwAEEBHs3Jf9ivT9RcgBYgAJISk/J/2Lm1Iqi6IK4gAlUfp2SO4Dmj4C6IF7OgZirEeuigEADbt5tYey85z+XJNhDIfSyD+PoSEq7PUpe5qa7nRgXoEDXV14RqKOZhc2IAQKOhAD/md+D7sR0QIAR8V98FYJfAOkHzkPtDAvwnAI2aPYs1w4KawYANPA8RIwtRgiMTSQhpqeYip+hJrcdgAIIIIHcwZECGyDg9re3wNKVEiKezYvKSaWI4IT/ZjlXowMkQAAFDlCy2FvA8NDogAUscAHcWx/3KOAAB1Bwfd1z/hMNeEB07cSIPD8MY4URQJnQj5ZHx+j7uKi98vV+AA54+fYkeP4vYjD96iMABV52AALoZdx3fdaXeXoDf51AGBmhAE7nL3rGZp3WACABIBNYgYJAFXcUDvyXfPPHAfV3fwaIe/k3e5ggfdR3eyaFdAJofxRQgBcwfSboCEVnEH7VCIf2/zlVNhMToC0EgBaB4YNcpg4dOIK3BwMUUAICWAIUAANG+IRGCIDLN4AveHs2MH2aR3QKqAmBUXenxDuI4TuYBgAMQjiGU4aF8ztDSBDS54FQ+Ia4F4MWMIPxlCFRsS2NoGrlY2MJ8XB/8Q9+mD6rN2n5sYWZEAARYC9k92+EWG68gGpZBmo514h3lwsb2HuMSIl16AsSgE3S5jGVqIlPZ4iYAGsdQ27bJIqABwxk0gpaN3PBICyuSIqqOGu9gImFWIuZiAsc4UQRt4m6mIrA0Ha7GIyc8IqooIG0qIo1uCmS+CHvZ4zC+AsMiFqhKI1xsoyXoADiRzzTNYnY6Am7x/9f1xiOvKaNluAAYwcav6ha5ugj6FgJ6PcXi+eO76iFw/B35XiPk1ByIvExqDiN/LgJQYcoAWmPA0mQ8dhFZDEBilSMCQkvCzkJKwQ235gIjbd4kEcINBFgyKh0EykJGCBt1vREijB6M3Z6g8CA3PaRSBSSkfBkx2YIUgZ8YEN8AkZMLQmTt4ZnEahng8B+6icITvQUAKCMEamQwjBupPWTD3OBAgAgFaAAEWA6SJmUh8iTj7BuB1kIOZhoOxiEXmRssuaSVaeVANWQA7UIlqaGGoGGhlN3B6c8ZrlFaNkI/TZ0f0M+rAYAgUhupmN8WHmOwVBwB7ePg7kI/ogWCtD/jgiZmKpyl4wgAQ8IjJDZj5K5CLLICnX5dXxFerl4mZEZi3gIkaKZgMHQRNPmiKdJWpmZC50JdK+JCAvwMdzGmq2pmLNpCFrWGc8Ijrmpm7WkAMPzIskYjcGZdbvpGE2xgaZwlcnpmrVkbDNpmdFpM8sJgcaml2GSnRPknbMQm7Ahno95nVgDnuGBniekniZnnuXHnq9Annkhn/DonsJJH/DJcvhpn9hJDRmZLwYmYP0QkPRJR/kZCShZegyhehLhEBFXoBYBoQBQk+wWfBBRNp9TEkfZYmHRoR76oSAaolrhnNBgfgqafmUiFU+hgZoiojkhLC6KEzAaoz0xoyFq/6MgSqLPYKIAoY4YqKJlSYv8U0dZU6QHulQUoYOCAIQ9OBM/sxZrCJz2Jh/lKY5H6ghtOYZw+TuLcRiJEaUCWaWmSSnfJ6Hrs2p86Jdo8Yd4FBrtQxOpAKfPeZvJSKecIKepZKf8uad82qd+6gz/Oadm9iGmEaiGYhpnpqeQEBCcIgiGWgmM2imJmg4JWgrGFgoGAUaViqkH4SGXiglbQ3qbakedQXqfag4U2pWeEGt46gmc0RSpOgqvym8z0aqVMCVNGl2/V6GUgKtCyKqK6g08SgpcI34zshLDmkpgVKzBGgmXlqyWcGkAwKzoAK2h8AABwCBUqaxNYa2eYBZLmv+tHfOblHBo3ioJhzZl4rqt5vCVCFcKgfmtK+GuhlKd8VoJHDEk9HoJ+WpqRlkOWVoKdbKu9ZgJfcF0ExCwonCwgFFKBIsJaDF2AUAAClsJEWsTNHF12lqw4KCHkxcKnZYRosF2FnSmeyirFhSypZEJxkYWHosJLauyI/unNFuzNnuzOJuzOruzPNuzPvuzQBu0O5uo/5hlA/CxQXm0Y6InDLBEjEAnzboIdAJqkapu3JkKTcuxg2Cr8kCW9nKUQLkPE0usTfG1ENisQaKqWxu2W4sWGBKqTmELmYKXxUcPwPpfYPtOABQRE7sADHApLnEv/4MBncKUYMMA/zMfVAL/kHy7AB3yD4Qxdok4H8ESExGAAQOAAahUbPDURJpLhgghMp2BIb76r232AA8AF4Zrtl9rL/wQAf+ooyvpD6gLFyECAQEKtu63AKi7uOZTt/OQETchE2A7dmuhEiDxPXomstoCIByRRzUGcWjhEWgTAMeLGNb7FhzhMZ3YThIRIjOxEFfHEKDTERpKCOsYbQDgEHPrGGwrCNIqNojBvogGvf+AEUTZThgBEprzImKHCBjRAPTLEdgKRjlzGh3jEA1hONMKvF2LKMSrEmRxGBM7UhI8rX2oEQ3hl/OiEROAEFo2FgxSwRO8vM3ZTn5RJgdBAH6BAeArawxyuUPJkR0C/xJgezlsZjYjJb+C4BAfYTEfDDL4S7wY0SkM4cLkSrzr205XthIfLDErjME36RJbVg9VHMF6JsEXfMNSLMUroRFfrLwtShNZbML5O8VTPDg3AWofjBDaApoTWhibxsVew7b9GrfEG8ZKjL9DnGUPoC3sisf4q8ccYxpRrBGH7MDxcMX4qxJ3cr3zccF63BYH4RFMxyAkoQDbVgHbFpV18hbT2gAU28jQ1RJalj66YxotbBMgYchqFkDtpBIVubVlqBQXO7Y8TLyUnGhoETE23MdHe4cHK2tDjL/FQxhN4QBwfMgJkcjDG7x1S8ogocl0LMlN4cGMSSwdAxLEwhYZ0f8AC6ASgNwvItW9eJTAT7FpfwFqDtEpzzsIDokY2pK/ClAIn9qyhFDM7fRwjSkIEqAtD+DDfbyme/jHgtxO/4wQGqFlOMfMaHyqV1OdhbDF50DNixBdNUEROaO1uijRHPm+4xABF4kIDJhNJsHJQpvSKr3SLN3SLv3SMB3TMj3TNF3TNn3TOJ3TOr3TPN3TPv3TQB3UQj3URF3URn3RqRUQ6qPUR00LmcotDUoRUe2YTa0Ks6puiVYSGRoSVR0L4JrPTwETYb2iNFrWZn3WaC0UUYsMXy2/LiHWb03WARAEZRAEaX3XeJ3XHSq7z9DWS1pja/GkoBwXTEBiLDADN7D/AfcVnWbKsIEhxV3aGJH9pca3ATcwAyTWAkoWArIVnGb6RVTcFKQxs6PdPr8hAx6gU5NxYh5wW5BppscYRTSAZC2QAIdNUd4VkbCtlAlk2RRVW4nNj7udjZpgVYY9AylmjMOdlZ9g2UmW3Mx4pasICpDx3Ivdk/tJCtVdF9BNaMtNKKS43ZVx3c7mC/zhH6EXpqYQHK3h2u+ybwrCIGCJmKCgHLlB3h2HnhrCIVfbCZ+iV6jA3sPx3uj5ImqGi54iBEWELABOCvbtYOu5YrFGfqeAlOc0K9FEZKIQHC2QIgz3C1EyJVVynCFyOd+yAzmAA6N1ChsgGTPQ2frZC61o/zbaSAREoAg8gAM5sAMNLgo0cBsiEFcrkm6ldCc/2N+cQAQH4IRJwjQggOIqrgom0gIsQDMg2QumGJX5IQa3pyUoMHKDkOM73uOh4AH4ZCDpdkia0qjTrSZHAuaCUE6jkFAw7pmcmMSOKHVxlwhyHgriZOWy+Wx5spqMmCVb0uRODuUrHgrt0ksv+QvFBmWhqCZejuiHIOY7QDukQOdnmSEjvY+Ufuh8DgQZECql8Od2+QsRMwmPKqAjHnm5S3mNoCYlYAI+hwggkAGTUwrtIgL4PXfomTO+ODEKDcdZRmMbw2cXqR8WkH1eZwg94FmgZeqhMAKSAehq9wvE6Hs+w/+rVpYYRFOPCHJ2KMB3hTBXsULtoNDrvy4PEpqsY9PAOow2YAmdlPByJlACll4IIJDuG37tKLFvEpA5m9OUa8a2fDZ8ZqiG9m4JF1ACXZeFxuLvjE4Z7e4O+4Y7unO1+zoIoYPMOlw6plsoKcBz+v5z/a4D6t4J1j5OhKTftQk+WBqG0ho8w1M8EYEYyEOXNEfrEX8I/a4CMbPuZ354Bf4/AZTe2saXaepqK8k+g8gJJc8BJcBJhFAAoJVenMDpwD6dnbHW3TkKarJ9wXYCP5ABP6Dhl4DqoqSehjvdoqBs12YIPuBZBUD0jj4P302YptBaFWcIK6ACKq/2lMD1m9f/C0ukmiZJ35kg91ZPCPeT4kPPCWzfct45lp2B5LyNCn6fdj5QALFSAFrvJhA+TZa/Co6vCCug4zm0CYICTNo+H3kUmrQ2ddBnCCeeA6KfCa/vG96p5omk+cTdCi93ALeu+jiQP5MPKW/i+1hOndo4STGAdI9fP1jP44S/CL1frd5Z5F9I+6/QWoO2CE+e4ovOLhbv/OzQ8K7QJ3/iCJhO5onQ8tguDvs2TJlP4nztCo0CCBcAg4SFhicgLxkvBY2OjSs+hoYhHyIjk5mam5ydnp+goAEBoaWmoQ0NAgMKGKevk6Ows58kJiaCoYiPjjgqGRkqOLyOXV8fIbTKy8yb/7LN0JsCCwIAEK7RoqTZzRe3JM0+K8SPKk0JUTkqKo0gKyvc8fIAz/PRAgQOAQ8D9s7b/mZd4ICiQ8BBHhJkWdGj0TodwHSsa/fuoMV/F5c5wBBAgAAIGQnVCxmqAwoO4A4m9KDpHQiHKiBmkMiOnE1i7lacmCeu4U1iK0aShFWhwlB6AI+CunAgV8CVplz+nFrgxTpgwVQwojp1XY4M6mpyLRA0qdJQCwJUiHBU6NlOTJ36g6r0hNSxN3tEmuX2LScIHgUokDC0r19NcS3SPXzWMGNDAh4QWKDgQWGzjzWR4ADDYqUamDKTdCwagAMCgwL0G425tKEYJUrEODhCA/8LGa4vkhYNYcCoAb4ZfJrAIACDCZMiVAhAeJCEUcIN7c4NA6XFGwlu5D44/fGAwIFXd3KwSoADQxIUKFC1YBB4kIW6u058UAYLDaG3y5N/WAKB/wA2xwk1lj0wTSEGLhCBAA0MIpwEHknXmn6F0BfQCDUgQ2E8/G2oSUekgFjId+1FSMiCDcY3oYcAWBhQJdqx2EyHMsYnQIg3FsKAYN9VQ0iCgxDw24osuuiPDC3MUOMyNC4JQAUfWSOAUYWkteNqE3wXHQBCqkZkkU1dNAILLOTnpClNDjWABBKwZQqKBKjC1ioARLDAAuS1FwF5vgXgZmpfgilXQDO0gNuZaAb/etg0vr3CgCoNREcnAR450B6X4OGjIqKTGOnPDRpyqo2HqmQqXkZp5uapPTCK+kmqIUnwwHrADQBfSLDOF+ZFSCrpKie5hsQAao0pWuOq84xZ5q8fGstYBQM8cClrzBoy0KCEGlqthDICFti0qDpbYwocYPtpqNsiJWOOE/BzWbqFkOtCSJUYAG+wGR1ozam6ibtkCiXMm5F9l2yL70UGDkAelbj6u2QHARskpgi3VXuwRe0KdmvD8E4CcQkSX2QAuqJe3HGzJxvSgQsg02uJmWeanHKQQ85sCMsphDSCCB+wxKnMM3fZqM2FuMBBzvS20ILPTgJNtNP6DYR0SB4o/820jFDLM8Fy0L1LtLXlHlX10jDrl3U8PXrEr0Vnb7cZAkp5oMEHM2yg3wgeGBCEw0qZF6DXXxsCMAUhk0SDAUobQENmMtwgQgIi6M33Ufq81bZ+K5sw9VEbzPCBBjccOhTePFviQWiXRwNBA6MYB3jgk9gQ9lt4F5qABgaEULY8MnjOQuixTK4meGtzJ3y1FnAg8GEjhGCABgkkecMGu9NCwwYGsEC36MHL6N/f1MK+yceFM9b4DNC3gHsI3INyvQHoJ3D7DKd3kno2BAgYvvibGG2BfjJwngZaMD8DGPCACDRg/Aq4gcWF4n7NSE+lkLM//iGGAzZg0Qg2cIMEev/QgA2kBQSZkYoAQKAVr7NgJlJgAheUT4XcYpGm6FE8TRDHOBQshHJcN4gdbkkkxztZByhQgs3BcFMsaoBk8ISNT/DJPOhRD58AkB4FTBGJR9wEAqyTRSxuaEceGQwoCAQAIIkkShHqCEhMBMQucmIzMHihCkfIjOes5YE5EhEhJGigBykgMgKIjtCCaLMhFtGNdJwFASbwvf/oD1h5zNGJHNCAP7piT5UUADYG6UZP2OAAGcxiImGBj7TR6RNQAglgGFZGfExAFQQw0CJh6cVOamJwcgzcKF/hp+K07oecgJOcAEAnDGiSMgKIgDExgMw/qcuWnehAdVJiwV3Cok3/znFmJx7FIEn1I2PmaQ84LRVDaHZiM6HknzVfMTTVpNCct2xhNQl5EAmwogHAUUAN/bFORJFPfP0MBaXAowBw9QueoXCB5mAX0FJAAJgVRGgnZGeujjU0FMCxHD2PSIIScAABs5nZRUWxT7ZtNIsWcMEBXPC/k430E4Cp1cYOKtFTxGCLJahoyU4aEFOWdB4vZZY3cJGuoG7IqEK9hU49RAIEIMACSOWEHbUZEE7WdBlDXWpuTPLRp0ZVE2AUzCP9YdWrYtWjMAgphSwgu4K0kUWVmYwDLBNRs9IiBSpFATUf04ELsOwAAdvrMz00Q3fW1a606IANbmGDXGakryg4/wAKbNDSTHw1E5Q0oQJmalLEcoMEkXWBES0SgwtEFgUXcOxbPSRB8+QwXJ6NRwyqU4KnjpYbFoCBR1Gr2nKyKH9KuWzgLgADCpjgACagAAxsq4wOWKCpJykBDCpbCuEaYgK9kVZbeBpbTqTAAggo7nGTu1wL3BYAzm1qcUtwAMAq9wJq5SV37WFKg3a2u0P5bniNi1zlrre9JVAuAkhggd4mal2kmIADfrqf+eIXFvodcIEDYl0EXWof73wwQx0sDwzgcwCpsNVwinOc5CwHmP957WA1rE4Ooy1TpxxPec5TiCpeEQBgJNZqWQxQFzOGjGZMDRp9FIE/znDHPNalj/+5AS3tiiKSSeFjIAdRqxmWNclK7hZ47PshKOuQkpZ8kgIi8B1iXRnLT1vyPRLsLlRGaZUIciUsTXnkFaPZZhUmhL56AwphJpOY/VhmM7+3sNfm+c5MUjM0ErawUHAzUu75poHCOaI62xnRLlV0MzK22e1iOs3eGyvHPi1STTMjo8UidallhCeNqjplhwaATzP86l/FujcypXWtd/rgWO96VB5aQLR0rOtfx8zUtIBQYKhKU2MzK88BKChlkO1bZ/P6qKsZWkbObG1EQRvGDI4Gt7vdNGrDoiOmKja5PeRrv7R73dVG7LvhjWR5m5veM7r3z/SNb2XMO7j87jdfAl7/boEv6d+eNjjWCH5whiv8gQ73xw1LbAgfnmg59kU4vDUOiifSeI9SpFORrRilWj58Oxz3BJD1JeQ1VgPOfzR0xE9uv5nvx8sgB6RwyixrTQmtT60LutCHTvSiG/3oSE+60pfO9KY7/elQZ7q2YY3zHoJZkz1HDc9/HvWuA6frT/862Mcu9rEfvexmL/rUT5ZKKbFSlq/EB5DIo79EjrCfl8u7zePh5zkF+ph/jMCOpMWgePPT1Hhfst6/9mhvAmCclzqheR5pd8QHfPH2SPm2iX2Q/1zE80oB/TxELw/S0/z0qE+96lfP+ta7vjQTVzE3Yj+J5/BwGbTPRIq1RmLZ/9fpxLDIvQ6BrwzgmjgAXO6kx/2xfMgEhrOvaL4hciwP6RNiR/qk6ymsT8WQh1sTz4nxiUIO/S6uPPnMOP/0qcjGWahfh0bmfDPe30MG+X6MkWkluNRITB+xU22TAHMCcH9HJCJ6xCFVp0OF528JKGvAYWkzkoBQ4gB/xEp4hCNR9kd9RAuUsjY8x3PmZICShIAYmAlBxhcSOGYgmA0imBQdwUyBdwot+GWZ1ESv0IGT8IEQ2EVtB2fy0INTcl1awgxAyEp0Jn/LUISFACWksIKhoIQ/Imc7CAo4aAhzJwCilkV9Nw9bKHJ8MgrMVgpd2A+ENiUEOAtjWCcMQhkKcP+GmpCGghaDryABE7hIgIZjkUENKQJPjecPfXiHAxUYSGgKfyh+ThgNhbgaj5aFnpCIjzdp5AQLpoQapyR5DsCIr5eJmriJnNiJnviJoBiKojiKpFiKpniKqJiKgdNIbpgJ9gRRs8BnhSCL9oNqjzEBBMBsaREAg2iKpgSLseBzI7gM3zF9gTJ490YpmBFLwxgkW6aKhFBmEKIAXMIcwwIAC8APRkFmmjQsH9Eb22Acz/F4vYEBzWEcqsEAsvIAyEEiA4AByFEcdYJ84KhD34EB/2GNuYgBwAEBFKQaEOA6QpKN7JiOPcSP5liNC8CP7WFMaxcYmBEBqAEl3/eJPJf/RoJxIwQCGBAgAargABAwUKwwZRlZDRQYABQ4J+bxRw1AHq5wj4BhGcUokn+0JR5pHsWRkbzoG8skJQ/QEf3QESRnRYFXZPqgHvTAIx6xJwyyNgc4CTtig6l4jwbiCh1xKQaCHBSYlKihjNiYI1DEfiBBDUZBJx1Bif1QjKZRDTOZI9TggppyldfHj3SygGapKXdJAFDCEWV2llLyH80oZBPySmMGjVRmHr6BHH7Zc4fJlZhCCl55Sl4ZmUGJl2npI8XYlpA5jH65mByJg6eUl3d4li/YOhHQmfjglcHYGh4pRoaZdTZCLExIRiACmJtJCjG2HsxIGKJJJ2UGJTJZ/w2TyZlxOUMkciVruQDI6Zd5CSGWQgAdiZqA6WSEQADL1JU5QgCWpHkI5YSLaQ0aiBwRoAqSkZ1gKR4SQB6QNpqW2XN/NADtKJzmCZeosZgS9B1kqAr46ZiiiSeVcprFqXWC4XyB8ZhJCR6vqUKTISQll6D4Bkat0IoOOqEUWqEO6h9VMgqc94oeQotURiWmZ6HzoJY6xAB/VJ3PiKJ7pwkkiofE0n4i2gzK1I+4qAq8aCNsJJFPIn6UAgH1SEX86I/ziBqnmYu8qJzYyA/4mAmnuQA/io4DoI4PwI6DkI0DQCUtCmJ65n8x2gwEwJPd+J4QBaN4aIM0GUhGGW3nMf+cvJiRURoZ+9AaZyoclcKSLvmVD8CRjFl/DEOmXaoMDECXl6kJMEqYzuSVbwkl7QEY/jGfPToIE3h7hoCo58mf/ZCVpkGNJAoYOeSnfwoLn+mbXFoI7deaj8Sm0smmqklDHgF9bMqeaLmnmel/SkSqo/qps3CcoroA+iORHpGLXLKdScGmECIZlcR+CqAaN6KaFRCSgwcA+lQIr9qb/TCb+aeW1AAuHtE6uJps70knyMRK6LatB1qgKmqg3HSJgwAYDWBMbboNC1Aq7AghPzStlRmr4BkZ8TkID7CH7oGg3fo1FeCv2bAgKxqwqIJ+y/AcYYiwDvuwEBuxEjuxFFv/sRZ7sRibsRq7sRzbsR77sSAbsiI7siS7bl2Sdiibsiq7sizbsi6bdr1YGl7ysjRbszZ7szibs2tnNgdrsbHGnRX6sz1bsUJbsrDFIkBLoUVrtPfFbua2AVALtdUDCjWgAcrwPFZ7EBpQA5sQAhqgAe1jCltrUUPbPSEhP2hrN7MAPbSQEJFjEQZwNYVAAwnAAopjCgaQAGobt2S7cCQhP1GLN4pzA4sjN6AzCDSAPjNwKF4rAgQ0CCEgAocLANgTuZfwPFdDA9BTN9gjAx5gN5E7uYcTAugTQGNbCJ37uZQruaABAHxbueiTDDNwOyxRtRqwuJRrAJ5rN51zu16b/wD047o+cwMaIALJAAB5Y7lhy7N++wnY80HQe0Bqawjyc0AAAD0foLc1kAA18DiE+wF2+wEfAAAhULeIkwDkCznby7V5C74JAL7Z60AAgCR1mzfvmwC5o77cS7nyg71KkwBX0774W74isL0iAAC347rvCz0JQAMsED1c2wIGkCEtoMDZawAbYL7FS0AswLUJvL6Pkwzp88AV3LxOCwrPG73QO72FgLbyc70JEBofIMF5CzrA+zx6+ziLw7aPgwnao8B2k8B5y8JDrMDH28MA8MMZbC9su8SFkLdHjL/ni8BWW8TbC7X4OwgbULXZa8SDoMOIW8RUDADgCwAjADkwPP8ID1wjS5sRL0wIbDsI0XNA9jsDB6S56JvGccy2RSzEevvEfyzGe4y+TtzEWUwIgizFBjTGRTzETkzAIbDGiQzIapvACTzGg8zGZWt4/vDGgxDHAPA4GJw3MlC3IbDFMpC3ufO42JG/B9zHVfzHiBzIstzKBMy/TEzIhzwIYowdIrABpMvItIzF9qLKIfC4vQy8KYy/QWy1IZy32pHJJnxU5ubJaTwII+A572svkSw/LEADtRE9jwsAGQI5mADLQEzJ6TwI5VwwhazL9jLL03u+aOzHduPIWTwm4oy+Yuy6BIQMNEBAB5zAO/O+XHvNoHzCSLvJEtvGTHt40/zQQMX/0PUm0dzg0BfhEz0ACyCgAjwACirwA6aI0QFxAjsQDCddAK8wDpLwCcEw0hQNKCFRABkg0gDAAz3gA2QBADoNDwUAAjxQAEEND+PAAyzdEJLwEnZhFSoABIPw0qVI0i2BF48AD4YAAsDADh+9Ahmg0lyt0mABDD6wCACgCDqdASuA1U6dAzoAAAUwDL8AAgAA1aQo1ZkwDlQNCZlQAF8BDO7Q1QDw1XO9A4TwCyegDm6N1oe9AzwA2CcABC+Q0nOtAjAd0SU9CDzwA8Eg2IJN11iNAxkg1zQND6AN2pKwAzkABEAA2HQ9inY9DwWgAu4A2kINFrHN2pQ9CCcADDmw/xOjDQA9kNVPrQMroNlgndt1HdOX5g8r8AszodIAoNk6QNuTXQilPQi/DQAQIdcAgNXBgNuVvdAWDdHiPd4TbdnmDQ2vnd7+ptyjZAHwDd8GxgnFpQwIQAEUwA31fQr7PQ8pQAE6dd/5LRAUcF7yhd7+0F4KTl2nQAEHQAtMgQJwkw0OHgoHMOAVbg83xeCEEOETXgoZDl7x1d4Ibg/tFd99BVI2MBsXgN+hFAMuQAGiNQgkQAEocFw0jgIUEErgBVoFcd9yEQMOzlLglQIX8D+gteODcFMkEOMpUOOdYQg1fuMPDgAWoONx1CL4rVctglwg5eA+bkR4pVwGseEkIP8XCHABKQA3HXDfXL7hAJDmNiDjHSDkK2UBMI7fWX4BKh4DiuXiFnBcTyXi6FVcM87kxfXhNVfi89BeTgU3Ds4BB5BbBwADkbXiHFBbHMABAEACgIUAOO7pKAADlR7nB5Dpp+5RB6BWLARYfH7qBzBgkkXqnWEB7RXpt7ArNP7poT7rkgUAow7qq07qHFDgDm4C7GUChRADmY5TVg7rAz4IsP7gHoUA7PVdsQ4AAHZconVcOWUBFIAAKjUvkT7pDg4D1TEQF/7q/1PtHhUDtn7hkq5VMl3engBej57v+r7vHK7tCv7gDi4xHGACTnXhn+QC9z3pkTUbFR5ZBuFRpv7/Pxce8YWAAJNu6inh8AAA8bYO6Q/e8YWw8ADQ8LEu7ABwU/wl8Rhe5exVCJ8EDqSO7VFeCIA1CClw4eIe6yA/8R0w8RbfUn7l4Pkd8ABw8wLD8FX+8zffGZ5OWdnu6YqOEfbeCfi+71af7/3eXoWQ4dpO8E716gjvVHY+CBWe4RX+89qe32hPCGi/9mb/8dle4SBPCG8/8iUv9pnuVxc/8XZP9lU+CG0/6XNP8wNu6+HuVPCd7Xzv8xdP64bf98+u6Bn+8yDf8ZWf7Z6w3vKg9XT/95H1VHx+8yVAYDCw5rFuCw/+SbKOAhTP+NQV+C2l+qIe+X0/+KY+YDj+SSjw/1wsJVngvvcmgOd1Twg3v/smwOm2L+3RvulHbgNHrvgD7vp2f+YTz/WbTgIdNf2m/z8Df+UHgO1wk/woM/UWwfl+TwgrI+kf1ensBVh+fuw4DgDVIVkGgfbSz/YXv/byL+luBQgWBwgAFAcAgoQAix2GJiaHAAiQBygALgccJQcWkgcHKYaLoouLF5AlKYiDpaUHFKUpKJ8mJIkAr4u5CJwAKRyvuaS+s7kkwDa8nSmbJherhLet06UBAdTY2drb3N3W3eDh4uPk5ebn6Onq6+bf7O/c7vDz9PX29/j52PL67Pz9AAMKHEiw3L+C4w4iXMiwocN0Ch9miyixosWLCJQpYgSgcaPHjyDRdbw4MqTJkyirXUtZMqXLlxZbSgwwwJrNmzhz6tzJs6fPn0CDCh1KtKjRo0iT0lyJkoDSp1CjSp1KtarVnwRgat3KtavXr2DDih1LtqzZs2jTql3Ltq3bt3Djyp1Lt67du3jz6t3Lt6/fv4ADCx5MuLDhw4gTK17MuLHjx5AjS55MubLly5gzLw4EADs=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Elevated levels of hematologic markers of thrombin generation (fibrinopeptide A and prothrombin fragment 1.2) obtained 12 hours after thrombolysis predict a higher 30-day mortality and reinfarction rate.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Granger CB, Becker R, Tracy RP, et al, for the GUSTO-I Hemostasis Substudy Group. J Am Coll Cardiol 1998; 31:497.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_45_4831=[""].join("\n");
var outline_f4_45_4831=null;
